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Abstract 
Abstract 
Many Chinese medicinal herbs and some marine algae have been reported to 
have antitumor effect to different extent. Many previous studies found that nearly half 
of the selected antitumor herbs exhibited antimutagenic activities. However, there was 
seldom research on the potential antimutagenicity (reducing the mutation effect of 
mutagens) and anticlastogenicity (reducing the amount of chromosomal damage 
induced by mutagens) of medicinal herbs and marine algae. In the present study, water 
extracts of nine Chinese medicinal herbs with antitumor effect including Ba Yue Zha 
{Akebia quinata (T.) D.), E Zu {Curcuma wenyujin Y. H. Chen et. C. L), Guang Fang Ji 
{Stephania tetrandra S. M ) , Jiu Jie Cha {Sarcandra glabra (T.) N.), M a Dou L ing 
{Aristolochia debilis S. et Z ) , Qian Cao Gen {Rubia cordifolia L ) , San Ling 
{Sparganium stoloniferum B. K), Shan Dou Gen {Sophora subprostrata) and Xian He 
Cao {Agrimonia pilosa L). and three local marine algae, Halymenia dilatata, 
Sargassum angustifolium and Sargassum siliquastrum were screened for anticlastogenic 
activity against direct-acting mutagen, ethyl methanesulfonate (EMS). Both in vitro and 
in vivo anticlastogenic activities were studied using single cell gel electrophoresis assay 
(Comet assay). Anticlastogenic mechanism of the water extracts was investigated with 
three in vitro treatment methods - pre-treatment, co-treatment and post-treatment. The 
anticlastogenic effect of different in vivo treatment schedule - pre-treatment, 
simultaneous treatment and post-treatment, and effect of route of administration in mice 
were examined and compared. 
All water extracts of Chinese herbs except Xian He-cao showed in vitro 
anticlastogenic activity to peripheral white blood cells of male BALB/c mice against 
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EMS. Ba Yue-zha, Jiu Jie-cha and San Ling also exhibited their anticlastogenic activity 
to male BALB/c mice in in vivo test. Three seaweed water extracts not only gave high 
anticlastogenic effect in the in vitro test but also in the in vivo test. Three 
antimutagenicity mechanisms - extracellular, intracellular desmutagenic processes and 
bioantimutagenic process were found in anticlastogenic processes of three algae but H. 
dilatata would much depend on bioantimutagenic process and S. siliquastrum would 
less depend on extracellular desmutagenic process. In the more effective intraperitoneal 
application, pre-treatment schedule would give more anticlastogenic effect than the 
other two treatment schedules. These suggest that water extracts of all tested marine 
algae and Chinese herbs except Xian He-cao showed different degree of anticlastogenic 
activity against EMS. Three antimutagenicity mechanisms were involved in 
anticlastogenic activity of seaweeds. Pre-treatment schedule with i.p. application was 
effective method in the in vivo assay. 
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摘要 
摘要 
多種中草藥及一些海藻被發現具有抗腫瘤的功效。在研究這 
些具抗腫瘤功效的中草藥中，近半數被證實亦具有抗突變的功能。 
然而，有關中草藥及海藻的抗突變功能（即減少由誘變劑所引發的突 
變）及抗斷裂的功能（anticlastogenic effect,即減少由誘變劑所引發的 
染色體斷裂）的研究是甚少的。在本研究中，九種具有抗腫瘤功效的 
中草藥和三種生長在本港海域的海藻的水溶性提取物會被用作測 
試，以研究它們對甲基硫酸酸乙酯（Ethyl methanesulfonate, EMS)的 
抗斷裂反應。這九種中草藥包括：八月礼 (Akeb ia quinata (T.) D.)� 
莪朮� C u r c u m a wenyujin Y. K Chen et. C. L)、廣防己 ( ^S tephania 
tetrandra S. M ) 、 九 節 茶 QSarcandra glabra (T.) N.)、馬究錚 
(Aristolochia debilis S. et Z.��g草根 Qiubia cordifolia L.)、三棱 
(Sparganium stoloniferum B. H.)、山豆根 QSophom subprostrata)和 
仙鹤草 Ugrimoniapilosa L.) •，而三種海藻分別是：Halymenia dilatata, 
Sargassum angiistifolium (挾葉馬尾草）和 Sargassim siliquastrum� 
在這研究中會利用單細胞凝膠電泳測定法（或流星測定法）去測試提 
取物的體内和體外的抗斷裂反應°此外，研究中亦會採用前處理法 
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(pre-treatment)�共同處理法（co-treatment)及後處理法（post-treatment) 
去找出三種海藻的抗斷裂作用的機制。同時也會比較有關體内研究 
的不同實驗處理法 -前處理法、共同處理法及後處理法 -所引致的 
不同抗斷裂反應及不同用藥途徑（即腹腔注射法和口服法）的結果。 
實驗結果顯示在雄性Balb /c小鼠中，除仙鶴草外，所有被測 
試的中草藥水溶性提取物均能對抗由 e m s對血液中白血球所作出 
的斷裂作用。而在體内測試中，八月扎、九節茶及三棱更被鑑定對 
雄性B a l b / c小鼠具有抗斷裂效果。至於三種本港海藻的水溶性提取 
物，在體内及體外的測試中均顯示出很強的抗斷裂效果。而它們都 
能透過胞外和胞内的去誘變過程（desmutagenic process)以及生物抗 
突變過程 (bioant imutagenic p r o c e s s )來發揮其抗斷裂的作用。 n . 
dilatata的抗斷裂作用較依重生物抗突變過程；而S. siliquastrum則 
較少依重胞外的去誘變過程。 
這顯示除仙鹤草外，所有被測試的中草藥和三種海藻的水溶 
性提取物均對E M S有不同程度的抗斷裂效應。在海藻的抗斷裂反應 
中，，均涉及三種抗斷裂過程。同時也發現在體內測定中，腹腔注射 
法加上前處理法最能發揮抗斷裂的作用。 
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Introduction 
1 
INTRODUCTION 
In the rapid industrial and urban development, millions of tons of toxic 
pollutants per year were discharged and polluted our environment. Some of these were 
genotoxic e.g. polycyclic aromatic hydrocarbons (PAH), volatile organic chemicals 
(VOCs). It is known that the harmful effect of these genotoxic substances is the cause of 
DNA damage in organism. The damage could cause cancer formation and other somatic 
diseases, e.g. ageing, teratogenesis (Gebhart and Amtyunyan, 1991). The increase of 
these toxic chemicals in our environment not only threatens wildlife but also our life. 
Therefore, antigenotoxic study to find substances that could neutralize genotoxic effect 
of toxic chemicals is important today. Generally, there are two types of antigenotoxic 
study: antimutagenic and anticlastogenic study. Antimutagenic agent is refer to a 
substance which may reduce the mutation effect of mutagens and anticlastogenic agent 
is a substance which may reduce the amount of chromosomal damage induced by 
mutagens (Gebhart and Amtyunyan, 1991). In this project, anticlastogenic effect of 
different natural products would be studied. 
Chinese medicinal herbs have been used for treating various diseases for 
centuries and it is common to screen these natural products for medicinal values. In 
antigenotoxic screen of Chinese medicinal herbs, most of the studies were searching for 
antimutagenic properties (Lee and Lin, 1988; Liu et al., 1990; Lee and Tsai, 1991; 
Wong et al, 1992; Horikawa et al., 1994). In these studies, over hundreds of Chinese 
medicinal herbs were screened and nearly half of them showed antimutagenic effect 
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against mutation induced by aflatoxin B, benzo[a]pyrene or other mutagens in 
Salmonella typhimurium TA 98 or TAIOO and some could also reduce mutagens 
induced mutagenesis or tumor incidence in mice. Among these antimutagenic herbs, 
most of them were traditionally used as anticancer drugs (Lee and Lin, 1988; Lee and 
Tsai, 1991). In Chinese herbal medicine, more than three hundred species, mainly of 
plants, were reported to have anticancer properties (Au et al, 1990; Xhen, 1997). As 
there are still many anticancer Chinese herbs unexamined, this present project was 
designed to screen for anticlastogenic properties of nine Chinese herbs. They were Ba 
Yue Zha (Akebia quinata (T.) D.), E Z u {Curcuma wenyujin Y. H. Chen et. C. L), 
Giiang Fang Ji {Stephania tetrandra S. M.), Jiu Jie Cha {Sarcandra glabra (T.) K), Ma 
Dou Ling {Aristolochia debilis S. et Z ) , Qian Cao Gen {Rubia cordifolia L), San Ling 
{Sparganium stoloniferum B. K), Shan Dou Gen {Sophora subprostrata) and Xian He 
Cao {Agrimoniapilosa L). 
Besides terrestrial organisms, our oceans provide abundance of marine 
organisms for searching of various medicinal usage (Konig and Wright, 1996). For 
marine algae, although many natural products were found to have anticancer properties 
and several marine-derived anticancer drugs are in clinical trials, there was only a few 
marine algae had been screened for antigenotoxic effect (Konig and Wright, 1996). 
Therefore, three Hong Kong marine algae, Halymenia dilatata, Sargassum 
angustifolium, Sargassum siliquastrum, were also included for extraction and screening 
for anticlastogenic effect. 
As there are different mechanisms of inhibiting carcinogenesis processes, 
inhibitors could be classified according to their mode of actions. Watterberg (1990) 
classified inhibitors according to the time in carcinogenesis process at which they are 
2 
Introduction 
effective. Kuroda (1990b) summarized antimutagenesis into two processes, 
desmutagenesis and bio-antimutagenesis. As antimutagenesis processes may occur 
outside or within the cell, de Flora and Ramel (1988) classified inhibitors as 
extracellular antimutagens and intracellular antimutagens. According to de Flora and his 
colleagues (1992), inhibition mechanisms could be illustrated by three methodological 
variations: pre-treatment, co-treatment and post-treatment. Therefore, anticlastogenic 
mechanisms of Chinese herbal extracts or marine algae extracts could also be 
investigated following these three treatment methods. 
In the anticlastogenic study, there are different methodologies for detection of 
protective effect. These include micronuclei, sister chromatid exchanges and 
chromosomal aberrations end-point evaluation. However, the introduction of single cell 
gel electrophoresis assay (Comet assay) by Ostiling and Johanson (1984) greatly has 
increased the detection limit of DNA breakage. This methodology would be applied to 
study the in vitro and in vivo anticlastogenic effect of water extracts of nine Chinese 
medicinal herbs and three marine algae. 
With the aims at screening for anticlastogenic effect of water extracts from 
Chinese herbal medicines and Hong Kong marine algae and studying their action 
mechanisms, the project was divided into two parts. Firstly the water extracts would be 
firstly subjected to in vitro anticlastogenic screening and their anticlastogenic 
mechanism would be investigated in vitro. Secondly in vivo anticlastogenic effect of the 
water extracts was examined and it was attempted to correlate the in vivo results with 
the in vitro results. Furthermore, the in vivo action mechanisms of modulators would be 
studied. Besides, the effect of different routes of administration, i.e. intraperitoneal (i.p.) 
and oral (p.o.) administration, would be investigated. 
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1.1 A Brief Introduction of Cancer 
Cancer is a general term applied to a series of malignant tumors which are 
ill-regulated proliferation of cells. Early in 475 to 221 B.C., the term "tumor" was first 
described in medical monograph of China, the Yellow Emperor 's of Medicine. Until the 
12th century A.D., "cancer" was appeared in formal documentation (Au et al. ，1990). 
For traditional Chinese healers, cancer develops because weak or toxic blood cannot 
nourish body tissues and deficient blood allowing pollutants to accumulate in tissues to 
a toxic level would also cause malignant tumor (Swerdlow, 2000). 
In the advance of technology, it is now clearer about the formation of cancer. 
The transformation of a normal cell to a cancer cell is a result of the loss control of two 
classes of genes, proto-oncogenes and tumour suppressor genes (Mann, 1999). 
Proto-oncogenes which control the growth, differentiation, and proliferation of the cells 
could be changed by gene mutation or chromosomal damage to oncogenes. Besides, 
oncogenes can be transduced to a normal cell by DNA-containing papovaviruses 
(Macdonald and Ford, 1997). The harmful effect of oncogenes is their encouraging 
excessive growth of cells. For tumour suppressor genes, their mutation or damage will 
disrupt their ability to destroy defect cells. It is because these genes are responsible for 
coding enzymes that control DNA transcription, DNA repair, and other nucleus-located 
functions that will disrupt their ability to destroy defect cells. The subsequence of the 
damage of these two genes is the continuous multiplication of cells to form malignant 
cancer cells which will probably expand to other areas (i.e. metastasis). 
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In the rapid industrial and urban development, according to World Wilde 
Fund's report that millions of tons of toxic pollutants per year are discharged out to 
pollute our environment and most of them are genotoxic substances e.g. polycyclic 
aromatic hydrocarbons (PAH), volatile organic chemicals (VOCs). As these substances 
together with radioactive waste can cause point mutation in DNA or damage 
chromosomal structure, it is believed that the incidents of wildlife and even ourselves 
suffering cancer will increase. However in the absence of convincing epidemiological 
evidence, the impact of environmental and occupational exposure to chemicals on the 
increase of some cancer incidence is still controversial (Cahow，1995). 
The danger of cancer is their ability to multiply indefinitely, to invade 
underlying tissue and to migrate to other sites in the body and multiply there. If not 
treated as early as possible, it will cause death. SEER statistic reviewed that in the 
United States, there were estimated 1.26 million of cancer cases and more than a half of 
million of people (about 540,000) died in 1997. The mortality rate was 163.7 per 
100,000 persons. In 2000, although the number of cancer cases are expected to drop to 
about 1.22 million, more than 560,000 patients would be killed by cancer. As the death 
rate is high, an effective cancer treatment is being awaited. Of course, the ultimate goal 
of cancer treatment is total eradication of cancer cells. Nowadays, however, there is no 
any surgery and radiotherapy which could completely remove tumor cells. Moreover, 
once the tumor being in metastasis state, chemotherapy is the only option. So far，it is 
still a long way from effectively preventing and curing the disease, partly because most 
of the antineoplastic drugs bring on significant toxic and side-effects e.g. nausea and 
vomiting, constipation, urinary retention, central nervous system side-effects, itching 
and headache. Therefore many medical professionals are still looking for better 
5 
Literature Review 
anticancer drugs from natural products, hopefully with less side effects. 
1.2. Natural Products as a Drug 
1.2.1. Development of terrestrial plants as a drug 
Natural products have been used as medicine for centuries. Early in 500 BC, 
the Chinese began to use natural products as drugs in their prescriptions. About 500 
years later, there was record of an extensive use of plants as medicines in India (Harvey, 
1993). Nowadays, large numbers of plants are constantly being screened for their 
possible medicinal values, including anti-inflammatory, hypotensive, hypoglycaemic, 
amoebicidal, antifertility, cytotoxic, antibiotic and anti-Parkinsonism properties. In 
1985，it was reported that natural product research elicited 3500 new bioactive chemical 
structures of which more than 2600 were from higher plants. The increase in interest in 
pharmacognosy can be revealed by the increase in research expense of the American 
National Cancer Institute (NCI) from $ 2.7 million in 1985 to $ 3.8 million in 1991. 
With such a great investment, several drugs are found. For examples, diosgenin, an 
essential ingredient of first contraceptive pills, is a steroid hormone found in Mexico 
wild yams; sodium cromoglycate, for asthma treatment, was extracted from a 
Mediterranean plant; forskolin, from Coleus forskolis, can be used to treat heart disease, 
lung and eye diseases; antibiotic thiaubrine comes from various species of Aspilia (Bird 
C.，1991); taxol, an anticancer drug, is isolated from dry bark of the pacific yew, Taxus 
brevifolia (Kingston, 1993). 
Other than being used as drugs, plant products can also be applied as starting 
material for the semisynthetic preparation of other drugs. For example, plant steroids, 
diosgenin from yams and hecogenin from sisal leaves are used for the manufacture of 
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oral contraceptives and other steroidal hormones (Harvey AL.，1993). 
Today, over 50 % of the marketed drugs are either extracted from natural 
sources or produced by synthesis using natural products as templates or starting 
materials (Committee on the Ocean's Role in Human Health, 1999). In 1993，World 
Wide Fund for Nature estimated that there would total around 30 million plants species 
on earth for drug screening. However, the abundant and rich diversity of plants species 
is threatened by forests destruction and at least 50,000 species are lost each year in 
forests destruction (Harvey AL., 1993). Therefore, i f there was still no any forests 
protection policy or action, it is believed that no more plant would be left for drug 
discovery in someday. 
1.2.1.1. Anticancer drugs from terrestrial plants and Chinese medicinal 
herbs 
Plant materials have been used in treating malignant diseases for centuries. 
There are at least 1400 genera of plants reported for against cancer (Dewick, 1996). As 
most of these anticancer drugs could be cytotoxic to cancer cells or disrupt their mitotic 
division, cancer cells could be killed and prevent from multiplication. For example, a 
number of dimeric indole alkaloids extracted from Catharanthus roseus, resins from the 
root of Podophyllum hexandrum and usnic acid from lichens species of Cladonia, 
Cetraria and Usnea, have inhibitory activity toward different kind of cancer cells 
(Dewick, 1996). 
In Chinese herbal medicine, more than three hundred species, mainly of plants, 
were reported to have anticancer properties (Au et al.，1990; Xhen., 1997). Elemene, 
extracted from Rhizoma zedoariae, could inhibit human and murine tumor cells (Zheng 
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et al. ， 1997). Another Rhizoma species, Rhizoma coptidis showed cytotoxic effect to 
human stomach cancer cells (Liao et al. , 1997). According to the theory of traditional 
Chinese pharmacology, these herbs have four properties- cold, heat, warm and cool, and 
are divided into five flavors- acridness, sweetness, sourness, bitterness and saltiness. 
When herbal medicines are applied to therapy, different herbs properties and flavors 
will act together. Therefore, overall action of individual medicine should be considered 
in clinical application (Au et al , 1990). 
1.2.2. Development of marine organisms as a drug 
In comparison with terrestrial plants, the use of marine organisms in folk 
medicine is very limited because most of them are served as food or difficult to harvest. 
In fact, the diversity of life at higher taxonomic levels is greater in the ocean than on 
land. In the sea, any phylum organisms can be found and twelve phyla are exclusively 
marine. The ocean contains more than 200,000 described species of invertebrates and 
algae. However, it is estimated that this number is but a small percentage of the total 
number of species that have yet to be discovered and described (Committee on the 
Ocean's Role in Human Health, 1999). Because many marine plants and animals living 
in densely populated habitats are non-motile and only have primitive immune systems, 
they have to evolve some chemical compounds, secondary metabolites which are not 
necessary for basic metabolic processes, to help defend against predators, attract or 
inhibit other organisms from settling or growing on them, and to provide chemical cues 
to synchronize reproduction among organisms which require external fertilization 
(Konig and Wright, 1995). Moreover, the mechanisms by which they prevent 
encroachment or predation interact with the same or similar enzymes and receptors that 
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are involved in human disease processes. For example, many natural products have been 
identified that inhibit cell division, the process that is the primary target of many 
anticancer drugs (Committee on the Ocean's Role in Human Health, 1999). Therefore 
marine organisms is a more promising source of novel compounds with therapeutic 
potential. 
Marine organisms have been seriously considered as a source of bioactive 
compounds after the introduction of potential marine natural products as 
pharmaceuticals by Bergmann in the 1950s (Bergmann, 1951, 1955). There are at least 
two marine-derived pharmaceuticals available today. Ara-C, an antitumor drug is used 
to treat acute myelocytic leukemia and non-Hodgkin's lymphoma. Ara-A, an antiviral 
drug is used for herpes infection treatment. Both drugs are derived from nucleosides 
which are isolated from a shallow water marine sponge collected off the coast of Florida 
(McConnel et al. ，1994). Since then, various academic, government, industrial and 
private research laboratories have devoted great effort in discovering marine-derived 
pharmaceuticals. 
1.2.2.1. Anticancer drugs from marine organisms 
Since the mid-1970, a large amount of funding has been used to support 
marine-based drug discovery projects, especially in discovery of anticancer compounds 
discovery. As a result, several marine-derived anticancer drugs are in clinical trials. For 
example, Bryostatin，isolated from the bryozoan Bugula neritina, is a polyketide with 
both anticancer and immune modulating activity (Committee on the Ocean's Role in 
Human Health，1999). It is currently in Phase II clinical trials for treating 
non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and multiple myeloma. 
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Ecteinascidin 743，a complex alkaloid derived from sea squirts Ecteinascidia turbinata. 
It is also in Phase II clinical trials for soft-tissue sarcomas treatment in Boston. 
Discodermolide, a polyketide extracted from deep-water sponges Discodermia, is a 
potent immunosuppressive and anticancer agent. It can effectively be used against 
breast and other types of cancer that have become resistant to other microtubule 
disrupting drugs. Halichondrin B，derived from Lissodendorys sp., also has the same 
effect (Committee on the Ocean's Role in Human Health, 1999). 
1.3. Anticlastogenic Study - an Anticancer Study 
It is known that damage of proto-oncogenes or tumor suppressor genes will 
cause cancer (Mann, 1999). The DNA damage induced either by chemical or physical 
means could be varied (Figure 1.1). In theory, genotoxic effects are related to any 
defined damage of the DNA helix and may also include the organization of DNA (e.g. 
chromosomes and chromosome movement). 'Mutagenic effect' which is mostly an 
alternative term for genotoxicity is refered to mutations in a single or multiple genes. 
'Clastogenic effect' is the damage that affects the chromosome structure, including a 
wide range of damage to the chromosomes or the chromatids. Therefore, substances that 
induce DNA damage is genotoxic but those that inhibiting its genotoxic effect is called 
antigenotoxic modulators. Different to cytotoxic anticancer substances, antigenotoxic 
modulators is to prevent cancer formation by blocking genotoxic substance or assisting 
DNA repairing but not to kill the cancer cells directly (Gebhart et al，1991). Based on 
the genotoxic end-points, there are at least two different aspects of antigenotoxic 
research- antimutagenic and anticlastogenic study. 
Alkylating agents are well known mutagens and clastogens. These include 
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many chemicals (Table 1.1) and they are classified into mono-, di-’ or polyfunctional 
alkylating agents according to the number of alkylating groups they carry (one, two, or 
more alkylating group) (Figure 1.2). For directly acting ethyl methanesulfonate (EMS) 
which possesses electrophilic properties and will react with nucleophilic molecules 
DNA, its clastogenic effect is the result of alkylation of N-7-guanine in DNA (Figure 
1.3). The alkylated guanine will hydrolyze from DNA to form unstable depurinated 
DNA molecule which will eventually be broken by P-elimination. (Freese, 1971; Singer, 
1983). It is suggested that methylation of 0-6-guanine in mammalian cell by 
methylating agents would probably cause mutational lesion (Walum et al , 1990). 
Generally, the approach of anticlastogenic screening of natural products is 
similar to the most commonly used antimutagenic screen test with bacteria which is 
investigated by mixing together with a known mutagen and the candidate modulator 
(Wall et al.，1990). I f the screening is to test for the anticlastogenic effect to 
mammalian cells, the bacteria should be replaced with mammalian cells and mutagen is 
replaced by directly acting clastogen. The in vitro antigenotoxic screening procedure 
could be generally summarized as in Figure 1.4. 
1-3.1. Anticlastogenesis mechanisms study 
In anticarcinogenesis processes, there are different anticarcinogenesis 
mechanisms for different inhibitors and it is also possible for an inhibitor to have more 
than one mechanism to prevent carcinogensis (Wattenberg, 1990). Inhibitors could be 
divided into three groups based on the time in carcinogenesis process at which they are 
effective. The first group is those that can prevent the formation of carcinogens from 
precursor substances. The second group of compounds are called "blocking agents" 
11 
Literature Review 
because they can prevent carcinogenic chemicals from reaching or reacting with critical 
target sites in the tissues. The third group of inhibitors can suppress uncontrolled 
proliferation of cells which have been previously exposed to carcinogens. Therefore, 
they are also called "suppressing agents" (Wattenberg, 1990). Different to Wattenberg, 
Kuroda (1990b) suggested that antimutagenesis can be categorized into two processes, 
desmutagenesis and bio-antimutagenesis. As antimutagenesis processes can occur 
outside or within the cell, de Flora and Ramel (1988) classified inhibitors generally as 
extracellular antimutagens and intracellular antimutagens. 
In order to elucidate the mechanisms of modulators and evaluate the whole 
spectrum of possible effects, de Flora and his colleagues (1992) designed three 
methodological variations: pre-treatment, co-treatment and post-treatment. Their design 
was simply to treat bacteria Salmonella typhimurium with modulators either precede, 
coexist with, or follow exposure to clastogen. Pre-treatment procedure is designed to 
favor penetration of the modulator into bacteria cells prior to clastogen so it is possible 
to investigate intracellular reactions of the modulator with the clastogen, or 
interferences of the modulator with cellular pathways leading to genotoxicity. 
Co-treatment procedure is aimed to investigate possible reactions between modulator 
and clastogen occurring in the extracellular environment. In post-treatment procedure, 
clastogen has already incorporated into bacteria cells and started DNA-damaging 
activity. The addition of the modulator can reveal possible effects on DNA repair, 
fixation and expression of DNA damage. Dauer et al (1998) and Loarca-Pina et al. 
(1998) separately applied this method to investigate the antimutagenic mechanism of 
proanthocyanidins from bark of Hamamelis virginiana and ellagic acid on direct-acting 
mutagenicity ofalflatoxin Bl . Besides bacteria as a testing model, Tesfai et al. (1998) 
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used normal human fibroblasts as a model to test for the antimutagenic mechanism of 
chromium on mutagen benzo[a]pyrene diolepoxide. 
1.3.2. In vivo anticlastogenic study 
As in vitro assay alone is not enough in anticlastogenic screening study, in 
vivo anticlastogeinc test should be included for verification. Before a fully study of 
anticlastogenic effect of the candidates, a pilot experiment for the clastogenic effect of 
clastogen to animal model would be done first (Hayashi et al. ’ 1984). From the pilot 
experiment, we could find the optimal dose and optimal sampling time through 
multi-sampling at multi-dose level methods. 
To investigate the effectiveness of a modulator, a full time-course in vivo 
antigenotoxic study is suggested. According to Sasaki et al. (1990)，the time-course in 
v/vo antigenotoxic study can be carried out by treating potential modulator either before, 
simultaneous with or after clastogen treatment. It was found that this in vivo 
methodology was quite similar to in vitro anticlastogenic mechanisms study mentioned 
above. 
In the in vivo study, extracts are usually administered into animal model either 
through oral gavage application (p.o. administration) or intraperitoneal application (i.p. 
administration). Previous studies evaluated the effectiveness between p.o. and i.p. 
administration. Sugiyama et al. (1989) found that the clastogenicity of 
2-acetylaminofluorene in MS/Ae and CD-I mice was no different between i.p. and p.o. 
route adminstration. Although higher clastogenic effect of benzo[a]pyrene was detected 
in i.p. treatment than p.o. treatment in both mice strain, there was sti l l no great 
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Genotoxic 
Mutagenic Clastogenic Genomic changes Miscellaneous 
• Gene mutations • Chromosome and • Aneuploidy • Sister chromatid 
chromatid breaks • Polyploidy exchanges 
• Chromosome and • Chromosome and 
chromatid exchanges chromatid gaps 
• Strand breakage 
• Adduct formation 
• Apurinic sites 
Figure 1.1. Schematic overview of different endpoints measuring genotoxic effects 
Alkyl Halogens 
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Dichloroethane, 
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Alkyl sulfates 
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DialkyI sulfates Alkyl alkane sulfonates Mylerane 
Figure 1.2 Types of alkylating agents. To simplify the above formulas, all hydrogens 
attached to carbon atoms were left out. Al = alkyl group; X = CI. (Freese, 1971) 
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Table 1.1. Alkylating agents tested for mutagenicity in mamals, and their teratogenicity 
status (Kalter, 1971) 
Chemicals Mutagenic Nonmutagenic Teratogenic Nonteratogenic 
1. Nitrogen mustards 
Acetyl derivative of HN2 
Chlorambucil V V 
Cyclophosphamide ^ V 
Isopropyl-bis(p-chloroethyl)amine ^ 
Mannomustine / 
Mechlorethamine ^ 
Mechlorethamine oxide / 
2. Ethyleneimines 
Apholate Z 
Diethyleneurea ^ 
Ethyleneimine ^ 
Inproquone 
Triaziquone ^ ^ 
Triethylenemelamine (TEM) V -/ / 
Triethylenephosphoramide (TEPA) Z 
3. Methanesiilfonic esters 
1,4-dimethyl busulfan ^ 
Busulfan •/ -/ 
Ethylmethanesulfonate (EMS) Z V 
Isopropylmethanesulfonate (IMS) " V 
Methylethanesulfonate (MES) Z 
Methylmethanesulfonate (MMS) V V 
4. Other alkylating agents 
p-Propiolactone V 
Diepoxybutane Z / 
Diethyl sulfate Z 
A^-methyl-iV'-nitro-iV-nitrosoguanidi 
ne (MNNG) 
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Carbonium ion 
O polar 0 
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dR 
Alkylation 
？2H5 O Depurination ？2H5 j 
dR—OH + 《 N y ^ N H . < f Y ^ N H 
N人N人NH2 /N人N人nh2 
^ dR 
Figure 1.3. The formation of carbonium ion from EMS in polar solvents and alkylation 
of guanine with resulting depurination (Freese, 1971). 
In vitro antigenotoxic screen test In vitro antigenotoxic screen test 
with bacteria with mammalian cells 
Salmonella typhimurium TA98 Peripherial blood cells 
+ of BALB/c mice 
Ames S-9 liver preparation + 
+ Test substance 
Test substance + 
+ Ethyl methanesulphoate 
2-aminoanthracene + 
+ Culture medium and incubate 
Mix with top agar and incubate < 3 hours 
48-72 hours 
Figure 1.4. Antigenotoxic screening procedures of bacteria and mammalian 
cells (Wall etal，1990). 
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route-related differences (Awogi and Sato, 1989). However, Ashby (1985) found 
difficult in definition of the in vitro genotoxin of chloracetamide-N-metholol because it 
gave positive clastogenic effect in i.p. administration but negative in p.o. administration 
(Ashby et al. ，1985). Shelby (1986) responded that result from i.p. administration 
should also be considered although p.o. administration seemed to be a common 
exposure route. Therefore, both administration routes would be applied in the present 
study. However, the oral administration route is close to exposure route of human and it 
has a priority in the choice of administration route (Hayashi et al. , 1989). 
1.4. Anticlastogenic Study of Chinese Medicinal Herbs and Marine 
Algae 
It is well known that many anticancer drugs were extracted from terrestrial 
plants and marine organisms e.g. taxol and bryostatin. With the increasing interest in the 
medicinal usage of Chinese traditional herbs, many herbs had been tested for antitumor 
properties and it was claimed that about three hundreds traditional herbs have antitumor 
effect (Xhen, 1997). Other than cytotoxic testing of different cancer cell lines e.g. 
promyelocytic leukemia HL-60 (Liao et al , 1997; Zheng et al，1997)，Chinese 
medicinal herbs had also been screened for antigenotoxic effect using Salmonella 
typhimuhum (Lee and Lin, 1988; Liu et al ’ 1990; Lee and Tsai, 1991; Wall, 1992; 
Wong et al.，1992 Horikawa et al. , 1994; Okai et al.，1994). Similarly, many marine 
algae were studied of anticancer effect ( Ohigashi et al，1992; Zhuang et al，1995; 
Riou et al, 1996; Harada et al.，1997; Hiqashi-Okaj et al. , 1999). However, there were 
only a few reports about antimutagenicity of marine algae (Wall, 1992; Okai et al.， 
1994). From these antigenotoxic studies, it is clearly shown that mammalian cells were 
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seldom used as the testing model. As mammalian cells data would be more reliable than 
data from bacteria to predict in vivo results, it is worth using mammalian cells as a 
screening model. 
1.4.1. Selection of nine Chinese medicinal herbs and three marine algae for 
anticlastogenic screening 
Among antimutagenic herbs, most of them were commonly used as anticancer 
drugs (Lee and Lin, 1988; Lee and Tsai, 1991). Therefore, nine Chinese medicinal herbs 
with claims of antineoplastic effect were selected for anticlastogenic screen in the 
present study. They are Ba Yue Zha {Akebia quinata (T.) D.), E Zu {Curcuma wenyujin 
Y. H. Chen et C. L), Guang Fang Ji {Stephania tetrandra S. M)，Jiu Jie Cha {Sarcandra 
glabra (T.) N.\ Ma Dou Ling {Aristolochia debilis S. et Z ) , Qian Cao Gen {Rubia 
cordifolia L), San Ling {Sparganium stoloniferum B. K), Shan Dou Gen (Sophora 
subprostrata) and Xian He Cao {Agrimonia pilosa L). Some of their medicinal parts 
and properties were described and listed in Figure 1.5 (Au et al，1990)'. Ba Yue Zha 
(BYZ)，the medicinal part is its fruit which has bitter, sweet and cold medicinal 
properties. It could soothe the liver to regulate the circulation of vital energy, activate 
blood circulation to relieve pain and promote diuresis. E Zu (EZ), its medicinal part is 
rhizome and medicinal properties are bitter, acrid and warm. It could removes 
blood-stasis and activates circulation of vital energy, promotes digestion and has 
analgesic action. Jiu Jie Cha (JJC), the whole plant can be used and has acrid, bitter and 
slightly cold properties. Not only does it activate blood circulation and collaterals but 
also removes blood-stasis, wind, heat and toxin. Qian Cao Gen (QCG), its root is bitter 
and cold. Its medical functions are blood cooling, stop bleeding, blood-stasis dispersion 
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Figure 1.5. Photos of some Chinese medicinal herbs. 
Some of their medicinal part are shown in insert 
photos. A = Xian He Cao {Agrimoniapilosa L); B = 
Jiu Jie Cha {Sarcandra glabra (T.) N.); C = Ma Dou 
Ling {Aristolochia debilis S. et Z); D = E Zu 
{Curcuma wenyujin Y. H. Chen et C. L); E = San 
Ling {Sparganium stoloniferum B. K); F = Ba Yue 
Zha {Akebia quinata (T.) £>.); G = Qian Cao Gen 
(Rubia cordifolia L); H = Guang Fang Ji {Stephania 
m i B I ^ ^ H H tetrandra S. M). 
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and pain alleviation. San Ling (SL), the medicinally functional part is stem tuber. Its 
properties are acrid, bitter and mild. It could remove blood-stasis, activate circulation of 
vital energy and have analgesic action. Xian he-cao (XHC), its medicinal part is the 
whole plant and its properties are bitter, puckery and slightly cold. It could clear heat 
and toxin, stop bleeding and kill parasites (Au et al.，1990). 
For marine algae, more than thirty local species were collected from Tong 
Ping Chau, the most north-east island in Hong Kong SAR. However, only three of them 
were test for anticlastogenic proterties. They were Halymenia dilatata, Sargassum 
angustifolium and Sargassum siliquastrum. .. 
1.5. Methods of Investigation 
1.5.1. Extraction methods 
Extraction of active components is an important step for new drug search and 
discovery. There are several different extraction methods and are generally divided into 
three types, i.e. maceration, percolation and steam distillation. Maceration involves 
soaking the plant material in a suitable solvent, filtering and concentrating the extract. 
Percolation is a similar process but plant materials are thoroughly washed and refluxed 
with solvent. This method is usually the traditional way to prepare Chinese herbal drugs 
described in traditional medical literature (Chang, 1997). Steam distillation is a process 
to distill volatile oils in a special apparatus. In extraction, the choice of solvent is of 
paramount important as it determines what will come out or remain in substrates. I f the 
type of isolated compounds is not known, extraction would usually start with a 
non-polar solvent and the extracted residues wil l be extracted with a series of more 
polar solvents. As a result, several extracts with increasing solute polarity will be 
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obtained (Williamson et al.，1996). These extracts from crude samples are called 'crude 
extracts'. Once a biologically active extract is obtained, it may necessarily be 
fractionated and characterized in order to obtain a more purified substance as monitored 
by bioactivity-guided fractionation scheme. The fractionation can be done by 
chromatography, which includes column chromatography, thin-layer chromatography 
and high performance liquid chromatography. 
1.5.2. Single cell gel electrophoresis (Comet assay) 
In anticlastogenic study, there are different methodologies for detection of 
protective effect of natural product candidate and chemical compounds. These include 
micronuclei，sister chromatid exchanges and chromosomal aberrations end-point 
evaluation. However, the introduction of single cell gel electrophoresis assay (comet 
assay) by Ostiling and Johanson (1984) has greatly increased the detection limit of 
DNA breakage. 
DNA damage can be detected with the single-cell gel electrophoresis assay 
(SCGE). This technique was first introducted by Rydberg and Johanson in 1978. They 
embedded cells in agarose, lysed them and denatured their DNA with NaOH, then 
neutralized and stained the samples. In measuring the ratio of red to green fluorescence 
from samples, DNA damage could be quantitated. In 1984，Ostling and Johanson 
greatly improved this method which could show a positive dose-dependent relationship 
of lysed lymphoma cells exposed to gamma rays in DNA migration and level of 
exposure. In this experiment, treated cells were lysed and electrophoresed in agarose on 
microscope slides in neutral conditions. Therefore, this method is described as microgel 
electrophoreisis (MGE). .In addition to this neutral condition treatment which is 
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responsible for double-strand breakage, a single-strand breakage detection alkaline 
condition treatment was also developed by Singh and his colleagues in 1988 (Singh et 
a/. , 1988). Their difference was just unwound structure DNA of lysed cells in alkaline 
condition but not in neutral condition. 
In electrophoresis, charged DNAs move away from the nucleus under 
electric current pull. Together with relaxed and broken DNA fragments, which migrate 
further, they form a 'comet' like image after staining (Figure 1.6). Therefore, SCGE 
assay is usually named as 'comet assay' (Fairbairn et al. ，1995). 
This technique is particularly valuable is because: (i) It allows the detection of 
intercellular differences in DNA damage and repair in virtually any eukaryote cell 
population that can be obtained as a single-cell suspension, (ii) It requires only 
extremely small cell samples (from 1 to 10000 cells), (iii) Results can be obtained in a 
single day. (iv) Excluding image analysis system, the running cost of the assay is low. 
(V) Sensitivity for detecting damage in single cells is comparable to the sensitivity of 
other methods which measure average damage to a population of cells 
(McKelvey-Martin et al. , 1993) (Table 1.2). Several versions of the single cell gel 
assay are currently practiced in different laboratories, as shown in Table 1.3. 
As the comet assay is designed to evaluate DNA damage in individual cells, 
cells or tissues should be assayed to allow distinction between cells. Virtually any 
eukaryotic cell can be used to study DNA damage with comet assay and there are many 
varied methods for generating single cell suspensions but those methods should not 
introduce additional repair or DNA damage to the suspensions cells. 
In the most commonly examined human cells, lymphocyte, de Meo et al. 
(1991) reported considerable intra-individual variability of comet formation. Actually, 
22 
Literature Review • 
Figure 1.6 Photomicrograph of DNA molecules from a BALB/c mouse white 
blood cells (Magnification 200x, fluorescent dye, ethidium bromide). 
Table 1.2. Sensitivity of various assays for detection of DNA single-strand breaks 
(Singh, 1996) 
Lower limit of 
Single-strand breaks detection of DNA 
Assays in daltons of DNA X-ray dose 
(in rads)a 
Alkaline sucrose sedimentation 
(Lett et al，1970) 1 break / 2-5 x 1 5 0 0 
Nucleoid sedimentation 
(Lipetz et al，1982) 1 break / 2 x 10^  33 
Alkaline elution 
(Kohn et al., 1976) 1 break/2-3 x 10^  30 
Alkaline gel electrophoresis 
(Freeman et al，1986) 1 break / 3 x 10^  30 
Alkaline unwinding 
(Rydberg, 1980) 1 break 7 6-9x10^ 10 
Alkaline microgel electrophoresis (Singh 
etal.，1994) 1 break/2x10^" 32 
"Minimum amount ofX-radiation needed to produce detectable increase in DNA 
damage 
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Table 1.3. Overview of SCGE methodologies (Fairbaim et al , 1995) 
Time 
General methods & Composition (min) 
Slide Preparation A Single layer, 0.75% LMP 
B Sandwich, 0.5-1.0% LMP 
Alkaline Assay 
1 .Lyse A.i 0.03M NaOH, l.OM NaCl (pH~12.5) 60 
A.ii A.i + 0.1-0.5%SLS 60 
B.i 2.5M NaCl, lOOmM EDTA, lOmM Tris, 1% SLS, 
1 % TritonX-100 ( p H � 1 0 ) ， >60 
B.ii B . i + 1 0 % D M S O >60 
B.iii B.i + Proteinase K (20hrs) 60 
2. DNA unwinding A 0.03M NaOH, l -2mM EDTA ( p H � 1 2 . 5 ) 60 
B 0.3M NaOH, ImM EDTA ( p H � 1 3 . 0 ) 20-60 
3. Electrophoresis A.i 0.5-0.67V / cm 25 
A.ii 丨 . O V / c m 20 
B 25V, 300mA • 10.40 
C 20V 24 
D 0 . 7 8 V / c m I5 
Neutral Assay 
1 .Lyse A 0.5% SDS, 0.03M EDTA 4 5 0 � � 
B 2% SDS, 0.03M EDTA ’ 
C 2.5% SDS, 0.025M EDTA 1 
D 154mM NaCl, 1 OmM Tris, 1 OmM EDTA, 0.5% 4 
SLS 
2. Wash A 90mM Tris, 2mM EDTA, 90mM boric acid 2-16 
B Distilled water 5 
3. Electrophoresis A 0.55-0.67v / cm (90mM Tris, 2mM EDTA, 90mM 
borate) ’ 20-25 
B 2.5V / cm (117mM Tris, 3mM EDTA, 9 I m M 5 ' 
borate) 
. C 9V / cm (40mM Tris, 1 OmM EDTA, 20mM GAA) 3 
Stain A Acridine orange, 2p.g/ml 
B Anti-BrdU antibody DAPI, 5)^g/ml 
C Ethidium bromide, 20|ag/ml 
D Hoechst 33258 or 33342, 5 or 10|Lig/ml 
E Propidium iodide, 2.5-5fig/ml 
F YOYO-1 
Image Analysis A Visual 
A.i Damage-no damage 
A.ii Damage staging 
B Ratios 
B.i Length / width, head / tail 
B - i i Fpoint 1 / Fpo int 2, F h e a d / F ta i l 
C Length 
C.i Total or tail 
D Tail moment 
D.i F,aii X length 
D ^ DNA content 
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many parameters can affect the ability of damage detection. It have been reported that 
there are a variety of possible factors that may be responsible for differences in cell 
response including the age of the blood donor, the physical activity of the donor, and 
whether the donor smokes or not (McKelvey-Martin et al ， 1993; Fairbaim et al. ’ 
1995). Moreover, cell cycle status likely causes an additional level of complexity to the 
problem because chromatin structure affects the role of DNA during comet formation in 
both the alkaline and neutral assay systems (Olive et al. ，1992). 
During slide preparation, major consideration is to obtain stable gels for 
subsequent manipulations with low background fluorescent noise. Generally, cells are 
suspended in low melting point agarose with final concentration of 0.5-1% at 35-45°C 
and cast on a fully frosted microscope slide in single layer or sandwich by normal melt 
point agarose. Subsequently, slides with respect to double or single strand break 
detection are lysed in neutral or alkaline lysis solutions. In pre-electrophoresis wash and 
electrophoresis steps, different reported time can be attributed largely to the extent of 
damage and desired detectability. The desired voltage and time of electrophoresis will 
be dependent on the levels of DNA damage expressed in the cells and the salt 
concentration of the running buffer. After electrophoresis, slides are washed and usually 
stained with a fluorescent DNA binding stain for image analysis. As damage DNA 
shows less affinity to DNA stains after denatured and renatured processes, cells with 
damage DNA can be separated from those undamage. For the image analysis methods, a 
range from simply visual to sophisticate tail moment endpoint can be applied. However, 
an appropriate and commonly used 'descriptor' is important for comparing results from 
different studies. This 'descriptor' must be a single number capable of describing the 
complex changes observed as comet tail elongate and broaden with increasing damage 
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(Fairbairn et al. , 1995; Tice, 1995). 
Since variability in the application of the technique, it is difficult to compare 
comet assay results from different laboratories. Therefore, a standardized protocol must 
be adopted. Generally, the accuracy in measuring DNA damage depends upon several 
technical and biological factors, e.g. lysis condition and pre-electrophoresis wash step 
(Fairbairn et al. , 1995). Even with the adoption of a standardized assay protocol, it may 
still be necessary to tailor lysis and electrophoresis conditions to the expected level of 
damage. This is because the extent of DNA strand breaks will be vary depending on the 
agent used to induce damage, the nature of the lesions produced, the type and biological 
condition of cells or tissues exposed, the exposure time and protocol, and the amount of 
strand rejoining allowed. Cell cycle position has also been shown to affect the results 
obtained using both alkaline and neutral assays. 
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Materials and Methods 
2.1 Materials 
2.1.1 Chinese medicinal herbs 
Ba Yue Zha {Akebia quinata (T.) D.), E Zu {Curcuma wenyujin Y. H. Chen et C. 
L) , Guang Fang Ji {Stephania tetrandra S. M) , Jiu Jie Cha {Sarcandra glabra (T.) N.), 
Ma Dou Ling {Aristolochia debilis S. et Z ) , Qian Cao Gen {Rubia cordifolia L\ San 
Ling {Sparganium stoloniferum B. K), Shan Dou Gen {Sophora subprostrata) and Xian 
He Cao {Agrimoniapilosa L). were purchased from a local Chinese herb wholesaler. 
2.1.2 Marine algae 
Halymenia dilatata, Sargassum angustifolium, Sargassum siliquastrum were 
collected at 2 sites, Lung Lok Shui and A Ma Wan of Tong Ping Chau which is located 
at north-east from Hong Kong Island. The samples were collected in the period from 
December 1997 to June 1998. 
2.1.3 Animals 
BALB/c male mice (8-10 weeks old) were supplied from the Laboratory Animal 
Services Centre (LASEC) of the Chinese University of Hong Kong. They were housed 
under condition of 20-22 °C with 12-hours light-dark cycle and supplied with 
standardized pellet food' (Supastok Autoclavable Rodent Diet, Ridley Agriproducts, 
27 
Materials and Methods 
Australia) and tap water ad libitum. 
2.1.4 Chemicals and solutions 
Phosphate buffer solution (TBS), Ca^ "" and Mg2+ free 
The solution was prepared by dissolving 0.2 g of potassium chloride (Sigma, 
Molecular biology product, USA), 0.2 g of potassium dihydrogen phosphate (Ajax 
Chemicals, Australia), 0.917 g of di-sodium hydrogen orthophosphate (Ajax Chemicals, 
Australia), and 8 g sodium chloride (Ajax Chemicals, Australia) in 1 L distilled water 
and autoclaved. . 
RPMI 1640 Complete medium 
Firstly, RPMI 1640 medium was prepared by dissolving 10.39 g RPMI 1640 
(Sigma, USA) and 2 g sodium bicarbonate (Sigma, USA) in ultra-pure water and stirred 
thoroughly for 2 hours. It was made up to 1 L after adjusted to pH 7.2-7.3 and filter 
sterilized with 0.25 |im membrane filter. Secondly, fetal bovine serum (Gibco BRL， 
USA) was heat inactivated by incubating at 56 °C for 1 hour after it was defrosted in 
room temperature. Finally, complete medium was made by mixing RPMI 1640 medium 
with 10% heat inactivated fetal bovine serum, Fungizone® antimycotic (Gibco BRL, 
USA) in 1:1000 (v/v) and penicillin-streptomycin (Gibco BRL, USA) in 1:100 (v/v). 
Hank's Balanced Salt Solution (HBSS). Ca^^  and Mg2+ free 
The solution was prepared by dissolving 0.4 g potassium chloride (Sigma, 
Molecular biology product, USA), 0.06 g potassium dihydrogen orthophosphate (Ajax 
Chemicals, Australia), 8.0 g sodium chloride (Ajax Chemicals, Australia), 0.35 g 
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sodium bicarbonate, crystalline (Sigma, Tissue culture media and regents, USA), 0.048 
g di-sodium hydrogen orthophosphate, anhydrous (Ajax Chemicals, Australia) and 1.0 g 
D-glucose (Ajax Chemicals, Australia) into distilled water and adjusted to pH 7.0-7.4 
with final volume of IL. It was filter sterilized with 0.22 )im membrane filter (Millipore, 
Ireland) and stored at 4 °C. 
1 % SLS Ivsing buffer 
Lysing solution was prepared by dissolving 3.35 g ethylenediaminetetraacetic 
acid disodium salt dihydrate (Fluka, Switzerland), 13.14 g sodium chloride (Ajax 
Chemicals, Australia), 0.9 g N-lauroylsarcosine sodium salt (Sigma, USA) and 0.108 
g tris[hydroxymethyl]aminomethane (Sigma, Electrophoresis regeant, USA) into 80.1 
ml distilled water. The solution was kept at 4 °C for 30-60 minutes and mixed with 0.9 
ml triton X-100 (Sigma, USA) and 9 ml dimethysulphoxide (RDH, Germany) before 
use. 
Alkaline electrophoresis buffer 
The buffer was prepared by dissolving 12 g sodium hydroxide (Merck, Germany), 
1 g 8-hydroxyquinoline (Sigma, USA) and 3.72 g ethylenediaminetetraacetic acid 
disodium salt dihydrate (Fluka, Switzerland) in 980 ml distilled water and 20 ml 
dimethysulphoxide (RDH, Germany). 
Neutralization buffer 
The buffer was prepared by dissolving 48.5 g tris[hydroxymethyl]aminomethane 
(Sigma, Electrophoresis regeant, USA) in distilled water. It was adjusted to pH 7.5 with 
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hydrochloride acid and made up to IL. 
1% normal melting point agarose fNMA) solution 
The solution was made by dissolving 1 g SeaKem®LE agarose (FMC, USA) in 
100 ml hot distilled water and stored air-tightly at 25 °C. 
1.5% low melting point agarose (XMA) solution 
It was prepared freshly by dissolving 0.03 g NuSieve®GTG®agarose (FMC, USA) 
in 2 ml hot HBSS solution and kept at 45 °C. 
Ethyl methanesulfonate (EMS) 
Ethyl methanesulfonate (Sigma, USA) should be freshly prepared by mixing with 
dimethylsulphoxide, which acted as a vehicle to prevent EMS precipitating out in 
dilution with culture medium complete medium. 
Ethidium bromide staining solution 
Fifty micro-liter (50 of 10 |ig/|Lil ethidium bromide (Amersham life science, 
USA) was added into 100 ml distilled water. 
Ethidium bromide-acridine orange (EB-AO) solution 
EB-AO stock (lOOx) solution was prepared by dissolving 50 mg ethidium 
bromide (Amersham life science, USA), 50 mg acridine orange (Polysciences Inc., USA) 
in 1 ml 95% ethanol and made up to final volume of 45 ml with distilled water. It was 
stored at -20 °C. The working solution of EB-AO was made by diluting 0.1 ml stock 
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solution into 10 ml PBS and stored, light tight, at 4 °C. 
2.2 Methods 
2.2.1 Crude extraction of natural products 
2.2.1.1 Water extraction of Chinese herbs 
An amount of 15 g of a Chinese herb was refluxed with 400 ml distilled water 
for 3 hours. After filtering with cotton cloth, it was centrifuged at 8000 rpm for 20 
minutes at 4 °C. After further removing precipitate with Whatman No.2 filter paper, 
clear supernatant was dried in freeze dryer and dry powder was kept in a dessicator. 
2.2.1.2 Water extraction of marine algae 
Marine algae (seaweeds) were carefully rinsed with fresh water to remove 
substantial epiphytes growth, silt and sand. Cleaned seaweed was weighted and mixed 
with 3 volumes (w/v) of distilled water and blended for 4 minutes in a waring blender 
(Waring, USA). Homogenized seaweed was left standing for overnight at 4 °C. Then, 
it was centrifuged at 23000 g with Beckman centrifuge (Beckman J2-M1) and its 
supernatant was frozen in bottles with liquid nitrogen before putting into freeze dryer. 
The water extract dry powder was kept in a dessicator for future study. 
2.2.2 Test for the effective dosage of clastogen ethyl methanesulfonate (EMS) to 
BALB/c mice 
Before carrying out the anticlastogenic experiments, it was necessary to find out 
what dosage of clastogen EMS could introduce observable and measurable 
chromosomal DNA damage to BALB/c mice peripheral white blood cells in both in 
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vitro and in vivo. 
2.2.2.1 In vitro test 
Peripheral blood from male BALB/c mouse of 7-8 weeks old was prepared by 
piercing tail blood vessel with blood lancets (Feather, Japan) and collected in heparin 
(Sigma, USA) treated eppendroff. The blood was tested with different EMS 
concentration. Four different concentration of EMS, 9x10)4 mg/L，9x10^ mg/L, 900 
mg/L and 90 mg/L were prepared with DMSO and they were diluted 10 times with 
HBSS. 0.5 ml of each concentration was mixed with 10 ^il BALB/c mouse blood and 
incubated at 37 °C for 30 minutes. Then, they were centrifuged at 2500 g for 3 
minutes and washed with HBSS two times. After washing, the blood was resuspended 
in 0.15 ml HBSS. 60 of the suspension was mixed with 60 j^l 1.5% LMA and 
subject to the comet assay. The remainder was used for cell viability check. The 
solvent control was done with 10 % DMSO. The detail of preparing slides for comet 
assay and cell viability check will be described in the section 2.2.4 and 2.2.5. 
2.2.2.2 In vivo test 
Various concentration of EMS (7.5 mg/ml, 6.25 mg/ml, 5 mg/ml and 3.75 
mg/ml respectively) were prepared with 25% DMSO in physiological saline. They 
were injected intraperitoneally (i.p.) injected into BALB/c mouse in 0.2 ml / 25 g to 
result in dosage of 30 mg/kg, 40 mg/kg, 50 mg/kg and 60 mg/kg. The solvent control 
was done by 25% DMSO in physiological saline (You et al., 1994). After intervals of 
12 hours, 24 hours and 36 hours respectively, 5 |il blood was drawn from tail blood 
vessel, washed with HBSS and resuspended in 0.15 ml after centrifugation. 60 \x\ of it 
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was mixed with the same volume of 1.5% LMA and undergone comet assay. 
2.2.3 Anticlastogenic bioassays 
Anticlastogenic assay is aimed to find a substance which could reduce the 
amount of chromosomal damage induced by mutagens. In order to screen as much 
samples as possible in a relative short time, an in vitro anticlastogenic-screening assay 
was required. Possible anticlastogenic mechanisms were also investigated by different 
treatment methods - pre-, co- and post-treatment method. Samples with positive result 
in in vitro screening would be selected to subject to in vivo test and different in vivo 
treatment schedules would be applied to obtain maximum anticlastogenic effect. 
2.2.3.1 In vitro anticlastogenic screening 
Extracts was first dissolved in RPMI 1640 and diluted to four different 
concentrations. Together with the EMS control and solvent control, they were mixed 
with 4 111 BALB/c mice blood and incubated for 2 hours at 37 °C. Then, except the 
solvent control which was treated with DMSO, each was added with 4 |il of 1 % EMS 
and further incubated for 1/2 hour. Before ready for viability checking and comet 
assay, all samples were centrifuged and washed with HBSS twice. 
2.2.3.2 In vitro anticlastogenic mechanisms investigation. 
Three different treatments: pre-treatment, co-treatment and post-treatment, 
were applied during anticlastogenic mechanism investigation. 
(i) Pre-treatment 
Dry powders of water extracts were dissolved in complete medium and 
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diluted to different concentration. 0.5 ml of samples was added with 4 ^il 
BALB/c mouse blood and incubated at 37 °C for 2 hours. Then it was 
centrifuged, washed twice with HBSS and followed by culturing in 0.5 ml 
complete medium containing 80 mg/L EMS and 0.8 % DMSO for 30 minutes. 
Again it was centrifuged and washed with HBSS and resuspened in 0.15 ml 
HBSS. 60 fil of it was used to prepare slide for the comet assay and the other 
was used for cell viability checking which was described in the section 2.2.4. 
(ii) Co-treatment 
Dry powders of water extracts were dissolved in complete medium and 
diluted to different concentration. 0.5 ml of sample was added with 4 )li1 of 
1x104 mg/L EMS or 100 % DMSO which acted as the solvent control. They 
were incubated at 37 °C for 2 hours. Then 4 of BALB/c mouse blood was 
added and they were incubated for further 30 minutes. After washed with 
HBSS, the blood cells were checked for viability and prepared slides for the 
comet assay. 
(iii) Post-treatment 
4 of BALB/c mouse blood was added in 0.5 ml complete medium 
containing 80 mg/L EMS and 0.8% DMSO. They were incubated at 37。C for 
30 minutes. After washed twice, they were suspended in 0.5 ml water extracts 
in complete medium and incubated for further 2 hours at 37 °C. Again, they 
were washed twice before use for cell viability checking and comet assay. 
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2.2.3.3 In vivo anticlastogenic screening 
Water extracts of Chinese herbs or seaweeds were dissolved in physiological 
saline and diluted to different concentration. After 12 hours fasting, BALB/c mice in 
7-8 weeks old were orally feed using gavage tube with different dosage of samples, in 
a volume of 0.5 ml per 25 g of body weight. Saline was served as the solvent control. 
The mice were divided into 3 groups for the time-course study. After 6 hours, 12 
hours and 24 hours of sample treatment, they were intraperitoneally injected with 30 
mg/kg EMS, an effective in vivo dose obtained in the Section 2.2.2.1. At the end of 40 
hours of EMS treatment (the time interval that 30 mg/kg EMS gave strongest 
anticlastogenic effect), blood was drawn from the tail blood vessel and analyzed with 
the comet assay. 
2.2.3.4 Different in vivo anticlastogenic treatment schedules 
There were three different schedules: (i) simultaneous intraperitoneal 
application, (ii) pre-drug treatment, (iii) post drug treatment. 
(i) Simultaneous intraperitoneal application 
In order to investigate the effect between oral gavage (p.o.) application 
and intraperitoneal (i.p.) application, some extracts were selected to administer 
to BALB/c mice by intraperitoneal injection. In this treatment, sample dosages 
were same as those in oral gavage application and mice were not necessary to 
be fasted before injection in volume 0.2 ml / 25 g body weight. The time of 
administration of 30 mg/kg EMS was decided by the most effective time in the 
screening test. 
(ii) Pre-drug treatment 
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Different doses of the water extract of Sargassum angustifolium (0.5 
mg/kg，5 mg/kg, 50 mg/kg and 500 mg/kg) were i.p. injected to BALB/c 
mouse once a day for a total of 7 days and 30 mg/kg EMS was administered in 
the following day. Before administration of 30 mg/kg EMS, blood was drawn 
for cell viability testing. After 40 hours, blood was drawn for the comet 
analysis and cell viability test, 
(iii) Post drug treatment 
30 mg/kg EMS was firstly i.p. injected into BALB/c mice and 2 hours 
later，administration of S. angustifolium extracts was followed. About 12 hours 
later，S. angustifolium extracts were administrated once more. After 40 hours of 
EMS administration, blood was drawn for cell viability and anticlastogenic 
analysis. 
2.2.4 Single cell gel electrophoresis assay (Comet assay) 
Before starting the comet assay, agarose treated semi-frosted slides should be 
prepared. This was done by dipping the semi-frosted slide into 1 % normal melting 
point agarose and laid horizontally for solidification. Then, agarose at backside was 
removed and the slide was placed on hot plate to dry completely. 
Blood from in vitro or in vivo test was washed with HBSS and warmed at 37 °C. 
60 |il of it was mixed with 60 |li1 of 1.5 % low melting point agarose (LMA) which was 
warmed at 40 °C. 100 of the mixture was pipetted onto an agarose treated 
semi-frosted glass slide. A 25mm x 25mm coverslip was immediately placed on it 
without trapping any bubble. Then it was put on a plastic plate with ice placed 
underneath in an icebox. They were kept in dark for at least 10 minutes in order to make 
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sure the agarose completely solidified. After removing coverslip, the slide was dipped 
in 1 % SLS lysing buffer for 2 hours in dark at 4 °C. Different samples were lysed 
separately. 
At the end of lysing process, the slide was rinsed with distilled water and placed 
on the platform of electrophoresis gel tank (Savant HG350) without leaving space 
between the slides. As the electrode field was uneven at both sides and easily disturbed, 
slides were placed 1 to 2 cm away from both side walls and total number of slides 
should be the same in each run by placing some empty slides. Electrophoresis buffer 
was added to the tank carefully to cover all slides without trapping any bubbles in or 
between slides. The buffer was circulated by peristaltic pump (Cole-Parmer, Masterflex 
E77921-07) at a rate of 10 ml per minute. The volume of electrophoresis buffer was 
adjusted so that voltage and current could be set to 18 V and 300 mA by DC power 
supply (Savant PS250). After the slides were kept 20 minutes in buffer for denaturing 
the chromosomes, they were electrophoresed for 2 hours at the room temperature. All 
processes must be done in dark. 
When the electrophoresis process was completed, the slides were neutralized 
with the neutralization buffer for 5 minutes in 3 times. Then the neutralization buffer 
was drained out and the slides were dried in absolute ethanol for 10 minutes. 
After staining with ethidium bromide, the slides were observed with an 
epifluorescent microscope (Nikon Eclipse E-600 microscope with Hitachi KP-MIE/K 
monochrome CCD camera) using an excitation filter of 510 nm to 560 nm and barrier 
filter of 590 nm. 50 cells were randomly selected and their Oliver tail moments were 
measured with software KOMET version 3.1 (Kinetic Imaging Ltd., UK). 
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2.2.5 White blood cell viability determination 
Blood samples (20 |li1) from in vitro or in vivo assay were mixed with equal 
volume of EB-AO working solution. After mixing, it was immediately transferred to a 
slide，covered with a coverslip, and observed with an epifluorescent microscope (Nikon 
Eclipse E-600 microscope with Hitachi KP-MIE/K monochrome CCD camera) using a 
filter excitation of 495 nm. Live and dead white blood cells were counted with a tally 
counter. The live cells will fluoresce green, while the dead cells will fluoresce orange. 
Cell viability was determined as follow: 
White blood cell viability = Live white blood cells 父湖 
Total white blood cells 
2.2.6 Statistical analysis 
All results are expressed as median 土 semi-quartile distance (QD) except in vivo 
anticlastogenic results of Chinese herb SL and three marine algae which are expressed 
as arithmetical means 土 standard errors mean (SEM). Comparison of the treatment 
groups with the EMS control group was done by one-way ANOVA test. 
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Table 2.1. The summary of three treatment methods. 
Treatment Method 
Sample EMS 
P r e 、 2 hours ® 1/2 hour 
S T A R T • • E N D 
Blood 
Sample + EMS 
© 
Co V 2 hours 1/2 hour 
S T A R T • • E N D 
Blood 
EMS Sample 
Post ® hour V 2 hours 
S T A R T • • E N D 
Blood 
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Results 
3.1 Extraction amount of different natural products and cell 
viability checking 
3.1.1 Chinese medicinal herbs 
There were total nine Chinese herbs extracted as described in Section 2.2.1. 
Each Chinese herb gave different amount of water extract powder after processes of 
extraction and freeze drying. When the amount of water extract powder was compared 
to the amount of herbs used to extract, different extraction percentage were calculated 
(Table 3.1). The decreasing order of their extraction percentage was as follow: BYZ > 
XHC > QCG > E Z > JJC > SDG = SL> MDL > FJ. 
3.1.2 Seaweed 
Only three marine macro algae, Halymenia dilatata, Sargassum angustifolium 
and Sargassum siliquastrum, were used. Al l of them were collected from Tung Ping 
Chau. Their extraction percentages were as follows: Halymenia dilatata — 1.04 %， 
Sargassum siliquastrum - 1.21 %, Sargassum angustifolium - 2 .94 %. 
Although the surfaces of three seaweeds were broth dried, there were still large 
amounts of water present in their bodies, as revealed by their high moisture content. The 
moisture content of H. dilatata was 92 土 0.3 %， S . angustifolium was 80 土 0.7 %, S. 
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Table 3.1 The amount of water extract powder and extraction percentage of nine 
Chinese medicinal herbs. 15 g of dry weight of each of them was used to extract. 
Chinese Medicinal herbs Weight of water extract Extraction percentage • (%) 
powders (g) 
Ba Yiie Zha (BYZ) 5.7 ^ 
EZu(EZ) 2.6 17 
Guang Fang Ji (FJ) 0.9 6 
Jiu Jie Cha (JJC) 2.3 15 
Ma Dou Ling (MDL) 1.7 11 
Qian Cao Gen (QCG) 2.9 19 
San Ling (SL) 2.0 13 
Shan Dou Gen (SDG) 2.0 ‘ 13 
Sian He Cao (XHC) ^ 24 
1 Extraction percentage = 100 x (WEP / CMH) 
where WEP : weight of water extract powder, 
CMH : weight of Chinese medicinal herb used, 15g 
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siliquastrum was 81 ± 0.3 
3.1.3 Cell viability 
Viability ofpWBC^ in all tests, either in vitro or in vivo, was > 90 %. 
3.2. Effective dosage of clastogen EMS to BALB/c mice peripheral 
white blood cells 
3.2.1 In vitro 
In studying the clastogenic effect of EMS to mice pWBCs, the degree of 
chromosomal DNA damage was measured by Oliver tail moment (Kinetic Imaging Ltd, 
1996). It is the product of the distance and the amount of damage chromosome migrated. 
In in vitro test, it was found that the Oliver tail moment of EMS in 90 mg/L of the 
sample was 29.02, which was the highest, as compared to 16.63 for 9 mg/L and 10.26 
for DMSO solvent control. In the dosage of 900 mg/L and 9000 mg/L, white blood cells 
were damage so serious that they could not be measured, so only the data for the solvent 
control, 9 mg/L and 90 mg/L were obtained (Figure 3.1). 
3.2.2 In vivo 
In in vivo test, EMS gave measurable clastogenic effect of the sample as low as 
at 28 mg/kg and showed the highest effect at 43 hours after administration. At the 
dosage of 28 mg/kg, Oliver tail moment of pWBCs was increased from 17.48 at 4 hours 
after i.p. administration to 30.51 which was the highest at 43 hours after administration, 
and fell back to 17.32 at 7th days (Figure 3.2). When the dosage was doubling up to 56 
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Figure 3.1 Comet results of 50 peripheral white blood cells (pWBC) of 
male BALB/c mouse in 7-8 weeks old treated with different EMS conc-
entrations for 30 minutes at 37°C. 
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mg/kg, many non-measurable serious damage pWBCs were found as early as only after 
40 hours of i.p. administration. Thus its data was unreliable. This situation was even 
worse when the dosage was increased to 112 mg/kg and 225 mg/kg, chromosomal DNA 
of pWBCy were damage so serious that they could not be measured even after seven 
days. 
3.3 In vitro anticlastogenic screen test and mechanisms 
investigation 
3.3.1 In vitro anticlastogenic screen test 
3.3.1.1 Chinese herbs (Table 3.2) 
Water extracts of a total of 9 Chinese herbs were screened for anticlastogenic 
effects. They were Ba Yue Zha (BYZ)，E Zu (EZ), Guang Fang Ji (FJ), Jiu Jie Cha 
(JJC)，Ma Dou Ling (MDL)，Qian Cao Gen (QCG), San Ling (SL)，Shan Dou Gen . 
(SDG) and Xian He Cao (XHC). 
In BYZ, EZ and QCG extracts (Figure 3.3)，it was found that their tail moment results 
were clearly lower than the EMS control tail moment results. The tail moment results of 
BYZ was increased with a decreasing concentration and the lowest tail moment was 
7.83 at 10 mg/L. However, the tail moment results in EZ and QCG were decreased with 
a decreasing concentration and the decreasing trend was much obvious in EZ. The 
lowest tail moment result in EZ and QCG were 15.47 for 2.5 mg/L and 16.82 for 2.5 
mg/L, respectively. 
FJ，MDL and SDG had similar tail moment results and their different were small 
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Table 3.2 Percentage of chromosomal DNA damage reduction of different 
concentrations of Chinese medicinal herb extracts. 
Percentage of chromosomal DNA damage reduction ^ 
FJ MDL QCG SDG SL BYZ JJC XHC 
15.88% No 3 01% 21.40% No No 28 17% No No 
m g / L effect 2 effect effect 。 ' … e f f e c t effect 
5 27.50% No No 14 480/0 No No n 930/^  No No 
m g / L effect effect effect effect ° effect effect 
36.70% 1.97% 9.62% 31.18% 11.77% 14.24% 16.33% 12 39% No 
m g / L • effect 
U 〗 2 5 . 9 4 % 5.390/0 4.29% 15.79% 9.04% 16.04% 7 43% No Not 
_ m g / L • • effect Test 
1 Percentage of chromosomal DNA damage reduction = [(A - B) / A] x 100% 
where A : mean Oliver tail moment of EMS control 
B : mean Oliver tail moment of sample 
2 I f percentage of chromosomal DNA damage reduction is < 0, it is 'No effect'. 
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(Figure 3.4). The results of different concentrations were within the range from 15 to 18 
and they were close to the EMS control result (17.25). 
For JJC (Figure 3.5), all concentrations except the dosage of 2.5 mg/L showed 
tail moment results which were greater than the EMS control result. The tail moment 
decreased from 11.43 for 10 mg/L to 9.55 which was for 2.55 mg/L and increased back 
to 11.45 at 1.25 mg/L. With the tail moment result decreased with decreased 
concentration, the result of SL decreased from 31.37 at 10 mg/L to 20.52 at 1.25 mg/L. 
Although the tail moment results of higher concentrations were larger than the EMS 
control (24.44)，two lower concentrations had the results lower than that of EMS 
control. 
In XHC results (Figure 3.5), all testing concentrations had the tail moment 
higher than that of the EMS control. 
Based on the screening results, the anticlastogenic effect of different extracts 
could be demonstrated by calculating the percentage of chromosomal DNA damage 
reduction by different extracts. This was done by comparing the difference of tail 
moment results between the extract and EMS control to tail moment result of EMS 
control (Table 3.2). In this table, the results could be divided into four groups based on 
the degree of damage reduction. The first group was EZ, QCG and BYZ. They had 
higher reduction percentage. For EZ and QCG, damage reduction in all testing 
concentrations was greater 15 %. Both herb extracts also got maximum reduction 
percentage at 2.5 mg/L, 36.7 % for EZ and 31.2 % for QCG. BYZ showed the highest 
reduction at 10 mg/L, i.e. 28.17% and the other concentrations also showed reduction 
greater than 7 %. The second groups were MDL, SDG and SL. They had moderate 
reduction or protective effect. Al l of them had 2 to 3 concentrations showed reduction 
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effect. SL had no reduction effect at two highest concentrations but the two lower 
concentrations had effect greater than 10 % and maximum reduction percentage was 16 
% at 1.25 mg/L. MDL and SDG only had about 10 % reduction effect. The third group 
was JJC and FJ. Both of them showed weak anticlastogenic effect against EMS. Only 
one testing concentration of JJC and two testing concentrations of FJ demonstrated 
anticlastogenic effect. For JJC, although it had reduction effect greater than 12 % at 2.5 
mg/L，no effect was found in the other concentrations. FJ could only give the highest 
5.39 % reduction at the lowest concentration at 1.25 mg/L. The fourth group was XHC 
which did not have any reduction effect in any testing concentration. Except XHC, by 
comparing the maximum reduction percentage of each extract, the order of 
anticlastogenic effect was EZ > QCG > BYZ > SL > JJC > SDG > MDL > FJ. 
Obviously, Chinese herb extracts had different degree of chromosomal DNA damage 
reduction effect. 
For ECso estimation (Table 3.3), not all Chinese herb extracts were calculated 
for their EC50. Only herb extracts with at least 2 testing concentrations having positive 
effect against EMS were considered. From the Table, EC50 of four extracts were MDL 
(0.37 mg/L) < EZ (0.97 mg/L) < QCG (2.93 mg/L) < BYZ (31.57 mg/L). As lower 
EC50 meant stronger anticlastogenic effect, the order of anticlastogenic effect was MDL 
> EZ > QCG > BYZ. Except MDL, the order of anticlastogenic effect was same as the 
order evaluated from maximum reduction percentage. However, their dose-response 
correlations were low as shown by their low correlation coefficient results. 
In viewing of Chinese herb water extracts, only six extracts, EZ, FJ, MDL, QCG, 
SDG and SL were tested for clastogenic effect at concentration of 10 mg/L. Most of 
them got tail moment from 2.77 to 3.65 that was close to that of the solvent control, 
51 
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Table 3.3 Estimated EC50 of Chinese herb extracts in in vitro anticlastogenic effect 
against EMS. Chinese herb extracts with more than two effective doses were only 
considered to calculate EC50. 
Chinese herb Estimated EC50, Correlation coefficient, 
extract (mg/L) r 
MDL I 0.37 -0.3876 
QCG 2.93 -0.0630 
BYZ 3 1 ^ 0.8640 
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from 3.22 to 3.92. However, MDL with result of 8.32 was significantly higher than the 
solvent control. 
3.3.1.2 Seaweed 
Three seaweed water extracts, Halymenia dilatata, Sargassum angustifolium 
and Sargassum siliquastrum, were screened for anticlastogenic effect (Figure 3.6 and 
Table 3.4). Al l samples, except 2.5 mg/L of S. siliquastrum, had lower tail moment 
result than that of their EMS control. In H. dilatata, there was a trend of tail moment 
decreasing with decreased concentration. The lowest tail moment result was 9.66 at 1.67 
mg/L. S. angustifolium also displayed similar pattern with lowest moment at the lowest 
concentration, i.e. 8.80 at 1.25 mg/L. Al l tail moment results of different concentration 
were below 11.45. This was comparatively smaller than 15.84 of the EMS control. In S. 
siliquastrum, although there was a decreasing trend of tail moment with decreased 
concentration, from 14.80 at 10 mg/L, there were a sudden drop at 5 mg/L to 9.88 and a 
sudden raise at 2.5 mg/L to 17.02. -
When the data was transformed to percentage of chromosomal DNA damage 
reduction (Table 3.5), most concentrations of three extracts could have reduction 
percentage more than 20 %. K dilatata showed more than 25 % of reduction with the 
highest 39 % reduction at 1.67 mg/L but at 6.67 mg/L, it only had 9.97 % reduction. S. 
angustifolium, the lowest percentage was 27.72 % at 10 mg/L and it increased to a 
maximum of 44 % at 2.5 mg/L. S. siliquastrum was the only seaweed extract that had 
showed no reduction effect in the testing concentration of 2.5 mg/L. However, it still 
gave more than 37 % reduction effect at the concentration of 5 mg/L. When comparing 
the reduction effect among them, it was found that S. angustifolium exhibited the 
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Table 3.4 Tail moment results of in vitro anticlastogenic screening of different 
concentrations of marine algae extract. 
Tail moment, median (QD) 
“ 7 O!^ ^ E M S S o l v e n t 
mg/L mg/L mg/L mg/L mg/L control control 
Herb 
^ 
H. dilatata 14.26 11.32 ' 9.66' 10.31 ‘ 4.47 b 15 84 5 40 a 
(3.09) (1.40) (1.06) (1.44) (0.83) (1.90) (1.54) 
io 5 i s iV25 "TdmgTL" 
mg/L mg/L mg/L mg/L Herb 
onlj...： 
S. angustifolium 11.45 ‘ 9.24' 8.80' 8.94' 3.48 ‘‘ 
(1.26) (1.28) (1.52) (1.06) (0.69) 
S. siliquastrum 14.80' 9.88 ‘ 17.02 ‘ 12.45 ^ 4.74 b 
(2.17) (1.66) (4.10) (2.91) (0.94) 
a Values statistically significantly different from that of EMS control group (p<0.05). 
b Values statistically insignificantly different from that of Solvent control group 
(p<0.05). 
Table 3.5 Percentage of chromosomal DNA damage reduction of different 
concentrations of three marine seaweed extracts. 
Percentage of chromosomal DNA damage reduction, % 
6.67 mg/L 3.33 mg/L 1.67 mg/L 0.83 mg/L 
H. dilatata 9.97% 28.54% 39.02% 34.91% 
....19.fP.g/L 5 mg/L 2.5 m g ^ 1.25 mg/L 
S. angustifolium 27.72% 41.67% 44.44% 43.55% 
No 
S. siliquastrum 6.57% 37.63% effect 21.40% 
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greatest effect in the similar concentration. 
According to the level of their EC50 (Table 3.6), the order was H. dilatata < S. 
angustifolium < S. siliquastrum. However, the order of the anticlastogenic effect was H. 
dilatata > S. angustifolium > S. siliquastrum. Their low correlation coefficient indicated 
their low dose-response correlation. 
On the whole, water extracts of three marine algae clearly showed lower tail 
moment results than that of EMS control and resulted in more than 20 % reduction of 
chromosomal DNA damage in most concentrations. 
In clastogenic testing of three marine algae extracts, all of them had lower tail 
moment results than that of solvent control even at their highest testing concentration. 
3.3.2 In vitro anticlastogenic mechanisms investigation 
From the results of in vitro screening test, three marine algae extracts were 
selected to subject anticlastogenic mechanisms investigation that was described in 
section 2.2.3.2. 
3.3.2.1 H. dilatata (Figure 3.7, Table 3.7 and 3.8) 
Nearly all concentrations of H. dilatata had lower tail moment result than that 
of EMS control in all three-treatment tests. 
In the pre-treatment and co-treatment results, all concentrations had about the 
same tail moment result in the treatment. It was around 11 tail moment in the 
pre-treatment test and 14 tail moment in the co-treatment test, as compared to 14 and 16 
56 
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Table 3.6 Estimated EC50 of three marine seaweed extracts in in vitro 
anticlastogenic effect against EMS. 
Marine seaweed extract Estimated EC50, Correlation coefficient, 
(mg/L) r ， 
H. dilatata 0.83 -0.8453 
S. angustifolium 1.34 -0.8324 
S. siliquastrum 2 -0.4069 
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Table 3.7 Tail moment results of H. dilatata in three method in vitro 
anticlastogenic mechanism investigation. 
Tail moment, median (QD) 
H. dilatata Pre-treatment Co-treatment Post-treatment 
3.33 11.35a 1 4 . 3 ” 
mg/L (1.33) (1.78) (2.11) 
1-67 11.04 a 14.97 1105a 
mg/L (1.46) (2.00) (0.95) 
0.83 12.56 14.34 a 12.04 a 
mg/L (2.09) (1.85) (1.35) 
0.42 10.89 a 14.18 a 1168 a 
mg/L (0,99) (1.66) (1.31) 
EMS 13.46 16.16 18.20 
Control (1.62) (1.21) (2.19) 
Solvent 3.64' 5.66' 6.51 ‘ 
Control (0.70) 輕 (l.QQ) 
a Values statistically significantly different from that of EMS control group (p<0.05). 
Table 3.8 Percentage of chromosomal DNA damage reduction of H. dilatata in 
three methods in vitro anticlastogenic mechanism investigation. 
Percentage of chromosomal DNA damage reduction, % 
H. dilatata Pre-treatment Co-treatment Post-treatment 
3.33 mg/L 15.68% 11.45% 9.29% 
I.67 mg/L 17.98% 7.36% 39.29% 
0.83 mg/L 6.69% 11.26% 33.85% 
0-42 mg/L 19.09% 12.25% 35.82% 
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of EMS control result in the respective treatment tests. In the figure 3.7, H. dilatata 
showed much lower tail moment result (around 12) than that of EMS control (18.20) in 
the post-treatment test. However, there was an exception at the concentration of 3.33 
mg/L, which had the tail moment of 16.51. 
In chromosome damage reduction percentage, most concentrations in the 
pre-treatment test caused more than 15 % reduction. In the co-treatment, the percentage 
was lower and only about 12 %. However, the reduction effect increased to more than 
30% in most concentrations in the post-treatment test. 
As a result, H. dilatata had strongest anticlastogenic effect in the 
post-treatment test that gave more than 2 times or more reduction effect than that in the 
pre- or co-treatment. 
3.3.2.2 S. angustifolium (Figure 3.8, Table 3.9 and 3.10) 
In the pre-treatment test, tail moment results of corresponding concentration 
and the control were the lowest among the three treatment tests. S. angustifolium 
showed the lowest moment at 1.25 mg/L, i.e. 8.89. In spite of their lowest tail moment 
results，they did not exhibit the .highest percentage in chromosomal DNA damage 
reduction by the presense of the relative low EMS control tail moment result. The 
damage reduction was ranged from 28 % to 34 %. 
In the co-treatment test, the result was similar to that of the pre-treatment and 
the tail moment decreased from 12.05 at 10 mg/L to the lowest 10.47 at 2.5 mg/L. The 
percentage of chromosome damage reduction was increased from 25 % to the highest 
35 o/o. 
In the post-treatment test, tail moment decreased from the highest 14.36 at 10 
60 
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Table 3.9 Tail moment results of S. angustifolium in three methods in vitro 
anticlastogenic mechanism investigation. 
Tail moment, median (QD) 
angustifolium Pre-treatment Co-treatment Post-treatment 
10 9.70 a 12.05 a 14.36 a 
mg/L (1.10) (1.09) (1.19) 
5 9.25 a 11.30' 11.83 a 
mg/L (1.39) (1.51) (1.49) 
2.5 8.91 a 10.47 a 10.94 a 
mg/L (1.01) (0.97) (1.12) 
1.25 8.89 a 10.56 a 1186a 
mg/L (1.10) (1.12) (1.18) 
EMS 13.46 16.16 18.20 
Control (1.62) (1.21) (2.19) 
Solvent 3.64' 5.66^ 6.51 ‘ 
Control (0.70) ^ (1.00) 
a Values statistically significantly different from that of EMS control group (p<0.05). 
Table 3.10 Percentage of chromosomal DNA damage reduction of K dilatata in 
three methods in vitro anticlastogenic mechanism investigation. 
Percentage of chromosomal DNA damage reduction, % 
angustifolium Pre-treatment Co-treatment Post-treatment 
10 mg/L 27.93% 25.43% 21.10% 
5 mg/L 31.28% 30.07% 35.00% 
2.5 mg/L 33.80% 35.21% 39.89% 
1.25 mg/L 33.95% 34.65% 34.84% 
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mg/L to the lowest 10.94 at 2.5 mg/L. The decreasing trend was found similar to that of 
m vitro anticlastogenic screening test of S. angustifolium. With 18.20 tail moment of 
EMS as the control, the chromosome damage reduction was from 21 % to 44 %. 
Three results showed that S. angustifolium had similar anticlastogenic effect in 
three treatment tests 
3.3.2.3 S. siliquastrum (Figure 3.9，Table 3.11 and 3.12) 
In the pre-treatment test, tail moment results of different concentrations of S. 
siliquastrum was ranged from 9.05 to 10.77 and was lower than that of EMS control 
result, 13.46. As a result, the reduction of chromosome damage in the pre-treatment test 
was from 20 % to 29 %. 
In the co-treatment test, except 10 mg/L, all testing concentrations had tail 
moment result from 14 to 15 and was lower than EMS control result, 16.15. As 
compared to the corresponding concentrations in the other treatments, the tail moment 
results in the co-treatment were the highest and in turn chromosomal DNA damage 
reduction was the lowest in the co-treatment test. With all reduction percentage below 
15%, it had no reduction effect at 10 mg/L. 
The tail moment result in the post-treatment test had a decreasing trend with 
decreased concentration. With all moment result less than that of the EMS control 
(18.20)，it showed the lowest moment 10.79 at 2.5 mg/L. Although tail moment results 
in the post-treatment were not the lowest in three treatment tests, the damage reduction 
was the highest in the corresponding concentration, from 25 % to 41 %. 
From the results of the three treatment tests, the anticlastogenic effect of S, 
siliquastrum decreased from the post-treatment to the pre-treatment and finally to the 
63 
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Table 3.11 Tail moment results of S. siliquastrum in three methods in vitro 
anticlastogenic mechanism investigation. 
Tail moment, median (QD) 
siliquastrum Pre-treatment Co-treatment Post-treatment 
10 10.44 a 16.87 12.96' 
mg/L (2.48) (1.93) (1.14) 
5 10.77 a 13.83 a 13.57 a 
mg/L (1.55) (1.29) (1.28) 
2.5 9.50 a 15.06 10 79' 
mg/L (1.98) (1.71) (0.75) 
1.25 10.06 ' 14.4” • 1127a 
mg/L (1.47) (1.68) (1.78) 
EMS 13.46 16.15 18.20 
Control (1.62) (1.21) (2.19) 
Solvent 3.64' 5.66' 6.51 ‘ 
Control (0.70) {f iJ l) (1.00) 
a Values statistically significantly different from that of EMS control group (p<0.05). 
Table 3.12 Percentage of chromosomal DNA damage reduction of S. siliquastrum 
in three method in vitro anticlastogenic mechanism investigation methods. 
S. Percentage of chromosomal DNA damage reduction, % 
siliquastrum Pre-treatment Co-treatment Post-treatment 
10 mg/L 22.44% No effect 28.79% 
5 mg/L 19.99% ‘ 14.37% 25.44% 
2.5 mg/L 29.42% 6.75% 40.71% 
1.25 mg/L 25.26% 10.77% 38.08% 
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co-treatment. 
3.4 In vivo anticlastogenic screen test and mechanisms investigation 
to 
3.4.1 In vivo anticlastogenic screen test 
3.4.1.1 Chinese herbs 
From in vitro anticlastogenic screen test, all testing Chinese herb extracts could 
be divided into four groups according to anticlastogenic effect as describe in Section 
3.3.1.1. Three Chinese herbs were selected from three different groups to subject to 
further in vivo anticlastogenic test. They were BYZ, JJC and SL. Following the oral 
treatment method of in vivo screen assay as described in Section 2.2.3.2, they showed 
anticlastogenic effect at different dosage and time. 
For BYZ (Figure 3.10 and Table 3.13, 3.14 and 3.15), the tail moment results 
of most dosages after 6 hours and 12 hours of BYZ extracts administration were higher 
than that of their EMS control, 18.33 for 6 hours and 13.06 for 12 hours. Only at the 
dosage of 0.005 g/kg for 6 hours, the tail moment (16.52) was found smaller than that of 
EMS control. This in turn implied that except 0.005 g/kg at 6 hours, there was no 
reduction effect to chromosome damage at 6 or 12 hours. However, the tail moment 
results of three dosages, 5 g/kg, 0.5 g/kg and 0.05 g/kg were found smaller than EMS 
control results after 24 hours of BYZ extract administration, and the tail moment results 
was increased with decreasing concentration, from 11.81 at 5 g/kg increased to 14.89 at 
0.005 g/kg. Therefore, the percentage of chromosomal damage reduction was decreased 
from the highest 12 % at 5 g/kg to no effect at 0.005 g/kg. The calculated ED50 of BYZ 
at 24 hours was large (>25 g/kg) with correlation coefficient 0.956 as shown in Table 
66 
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Results 
Table 3.15 Estimated ED50 of three Chinese herb extracts in in vivo anticlastogenic 
effect against EMS. ED50 of each extract was calculated from data set with highest 
performance in chromosomal DNA damage reduction percentage. Their correlation 
coefficients were also calculated. 
Chinese herb Estimated ED50, Correlation coefficient, 
extract (g/kg) r 
JJC (6 hours') 0.11 -0.3753 
SL (12 hours) 0.22 0.2964 
BYZ (24 hours) >25 Q.9563 
1 The hour indicated the highest anticlastogenic effective time of the Chinese herb 
extract in in vivo anticlastogenic screen test. ‘ 
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3.15. 
For JJC (Figure 3.11 and Table 3.13, 3.14 and 3.15)，its results was totally 
different to those of BYZ. Just opposite to BYZ results, the tail moment result of all 
testing dosages at 6 hours was lower than that (23.82) for EMS control. However at 12 
hours after administration, there were only two testing dosages results lower than that of 
EMS control. When the treatment time was extended to 24 hours, all testing dosages 
results were higher than that of EMS control. At 6 hours after administration, the tail 
moment decreased from 18.13 at 10 g/kg to the lowest 11.38 at 0.1 g/kg and the 
chromosome damage reduction effect was higher than 20 % to a maximum of 52 % at 
0.1 g/kg. At 12 hours, the two lower tail moment results occurred at 10 g/kg and 1 g/kg 
with the tail moment 18.69 and 17.02 respectively. As compared to the EMS control 
(21.52)，their chromosome damage reduction effect was more than 10 % and up to 21 % 
at 1 g/kg. The calculated ED50 of JJC at 6 hours was 0.11 g/kg with correlation 
coefficient only -0.375. 
For SL (Figure 3.12 and Table 3.13, 3.14 and 3.15), all testing dosages with 
anticlastogenic effect occurred at 12 hours after administration. At 6 and 24 hours after 
administration, nearly all testing dosages gave moment results higher than that of EMS 
control. Similar to the positive results of BYZ and JJC, the tail moment was decreased 
with decreasing of dosage. The tail moment was decreased from 11.83 at 2.5 g/kg to the 
lowest 10.07 at 0.025 g/kg. With the tail moment of 20.25 for the EMS control, SL 
decreased more than 35 % of chromosomal damage and reached a maximum of 50 % at 
0.025 g/kg. The ED50 of SL at 12 hours was 0.22 g/kg and the correlation coefficient 
was low with only 0.296. 
In summary, three Chinese herbs extracts had different in vivo anticlastogenic 
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Results 
effect at different period of time intervals after drug administration. It was found that 
anticlastogenic effect of SL was at 12 hours and the highest effective dose was 0.025 
g/kg. JJC showed effect at 6 hours and 0.1 g/kg gave the highest effect, whereas BYZ 
had mild anticlastogenic effect at 24 hours with only 12 % maximum reduction at 5 
g/kg. The order of effective dose was SL < JJC < BYZ, whereas the order of ED50 was 
JJC < SL « BYZ. 
As SL got the highest anticlastogenic effect with 50 % reduction at 0.025 g/kg, 
an in vivo anticlastogenic test of SL at 12 hours was repeated again (Figure 3.13). The 
tail moment mean and standard error of EMS control was 17.64 土 2.72. It was decreased 
4 0/0 at 500 mg/kg (16.92 士 0.81) but there was no significant difference to that of the 
EMS control (P < 0.05). For the dosages of 50 mg/kg, 5 mg/kg and 0.5 mg/kg, the tail 
moment was increased to 17.82 土 1.97，27.15 土 2.35 and 25.73 土 2.79，respectively. 
3.4.1.2 Seaweed 
As shown by the good results in chromosomal damage reduction in in vitro test, 
all three marine algae were selected for further in vivo test. 
For H. dilatata (Figure 3.14), tail moment results in three time-course 
treatments had similar trend, increasing tail moment with decreasing dosage. Besides, 
from Table 3.16, it was found that the tail moment of the corresponding dosage 
decreased with increasing time treatment. In the increasing trend at 6 hours after 
administration, only the dosage of 22 mg/kg (10.93) and 2.2 mg/kg (11.75) had lower 
moment result than that of the EMS control (13.83). At 12 hours after administration, 
the tail moment was increased from 8.44 at 22 mg/kg to the highest 10.12 at 2.2 mg/kg. 
At 24 hours after administration, all testing dosages had tail moment results lower than 
73 
Results 
35 n 
30 - * * 
丨 k i l l 
Sol. 500 50 5 0.5 EMS 
Ctr. mg/kg mg/kg mg/kg mg/kg Ctr. 
Figure 3.13 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old treated with different concentrations of SL water extract followed 
with 30 mg/kg EMS. Each represents the median +/- S.E.M. of 3 treated 
mice.Values statistically significantly different from that of EMS control 
group are indicated by *{p<0.05). 
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Results 
10 and the lowest tail moment was 5.57 at 22 mg/kg. With respect to the chromosomal 
damage reduction as shown in Table 3.17，the percentage of reduction was generally 
decreased with decreased concentration. The percentage of the corresponding dosage 
was increased with increasing time treatment. This also revealed that the percentage of 
reduction was more than 38% to the highest 64 % at 24 hours and there was 27 % to 39 
o/o reduction at 12 hours. Even at 6 hours after administration, two dosages with 
reduction effect were greater than 15 %. The ED50 of H. dilatata at 24 hours was 0.78 
mg/kg and correlation coefficient was 0.924 (Table 3.18). 
In in vivo anticlastogenic screen (Figure 3.15 and Table 3.16)，S. angustifolium 
showed lower tail moment results than that of EMS control in all testing doses after 6 
hours. The tail moment was increased from 11.11 at the highest dosage of 1 g/kg to 
40.06 at the lower dosage of 0.01 g/kg. At 12 hours and 24 hours after administration, 
most dosages had higher tail moment results than that of the EMS control results and 
both results showed a trend of decreasing with decreased concentration. Only 
anticlastogenic effect after 6 hours showed reduction of chromosome damage and it was 
more than 35 % to a maximum of 82 % at 1 g/kg (Table 3.17). The ED50 of S. 
angustifolium at 6 hours was 11.17 mg/kg and the correlation coefficient was 0.846 
(Table 3.18). 
By comparing the results of 6 hour and 24 hour groups, S. siliquastrum showed 
a clear lower tail moment results than that of the EMS control (55.55) at 12 hours 
(Figure 3.16). The tail moment was decreased with dosage from 35.14 at 200 mg/kg to 
28.44 at 0.2 mg/kg. At 6 hours, the tail moment was also lower than that of the EMS 
control. The results were around 72 as compared to 85 of the EMS control but it had a 
sudden drop to 41 at 20 mg/kg. Similar to 6 hours results, 24 hours results were around 
77 
Results 
Table 3.18 Estimated ED50 of three marine seaweed extracts in in vivo anticlastogenic 
effect against EMS. ED50 of each extract was calculated from data set with highest 
performance in chromosomal DNA damage reduction percentage. Their correlation 
coefficients were also calculated. 
Marine seaweed | Estimated ED50, Correlation coefficient, 
extract (mg/kg) r 
H. dilatata (24 hours) 0.78 0.9237 
S. angustifolium (6 hours) 11.17 0.8456 
S. siliquastrum (12 hours) 0.38 -0.9471 
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Results 
30 but they were higher than that of the EMS control (29.84) except the dosage of 20 
mg/kg which only had 19.53. When reduction damage was calculated, the reduction 
effect was increased from 6 hours (about 15 %) to 12 hours which had reduction 
percentage more than 35 %. However, it was decreased to no effect in most dosages at 
24 hours. The ED50 of siliquastrum at 12 hours was 0.38 mg/kg and the correlation 
coefficient was -0.947 (Table 3.18). 
The strongest anticlastogenic effect of each of three seaweed extracts appeared 
at different period of time interval after extract administration. For H. dilatata, it was 
strongest at 24 hours and S. angustifolium was strongest at 6 hours whereas S. 
siliquastrum was at 12 hours. Their anticlastogenic effects were greater than 48 %, ant 
the highest was 82 %• These results were served as guideline for repeating in vivo 
anticlastogenic test in triplicate. 
vivo anticlastogenic effect of three seaweed extracts were repeated. As 
shown in Figure 3.17, Table 3.19 and Table 3.20, H. dilatata had significantly lower tail 
moment at 22 mg/kg (9.07 土 0.66) and 2.2 mg/kg (9.82 士 1.16) than that of the EMS 
control (14.21 士 0.24). With comparable results to the screening test, the percentage of 
chromosomal DNA damage was decreased to 36 % for 22 mg/kg and 31 % for 2.2 
mg/kg. However, the estimated ED50 (8945 mg/kg) was greatly difference to its ED50 
estimation (0.78 mg/kg) in screening test (Table 3.21). 
In S. angustifolium, the anticlastogenic effect was stronger at 1 g/kg and 0.1 
g/kg than that of the lower dosage and their tail moment results were significantly 
different from that of the EMS control (P < 0.05) (Figure 3.18). This was same as the 
screening test result but the chromosomal damage reduction was decreased to 28 % for 
1 g/kg and 17 % for 0.1 g/kg (Table 3.19 and Table 3.20). In ED50 estimation (Table 
81 
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20 n 
18 -
16 - T ^ ^ 
I 12- * * • _ 
_ _ . — 
Sol. 22 2.2 0.22 0.022 EMS 
Ctr. mg/kg mg/kg mg/kg mg/kg Ctr. 
Figure 3.17 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old treated with different concentration of H. dilatata water extracts 
followed with 30 mg/kg EMS. Each represents the median +/- S.E.M. 
of 3 treated mice. Values statistically significantly different from that of 
EMS control group are indicated by * (p<0.05). 
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Table 3.19 The tail moment results of in vivo anticlastogenic test of three seaweed 
extracts. 
Tail moment, mean 土 standard error 
H. dilatata S. angustifolium S. siliquastrum 
22mg/kg 9.07 士 0.66 lOOOmg/kg 21.27 士 3.56 lOOOmg/kg 11.48±1.51 
2.2mg/kg 9.82 土 1.16 lOOmg/kg 24.70 士 5.53 lOOmg/kg 12.30 士 0.72 
0.22mg/kg 14.84 士 1.48 lOmg/kg 35.29 ±4.78 lOmg/kg 11.53 土 2.44 
0.022mg/kg 15.83 士 0.45 1 mg/kg 37.59 土 1.00 1 mg/kg 10.56 土 1.12 
EMS 14.21 士 0.24 EMS 29.69 士 1.99 EMS 16.78 土 0.59 
Control Control Control 
Solvent 4.79 士 0.20 Solvent 7.32 土 1.44 Solvent 5.16 土 0.59 
Control Control Control 
Table 3.20 Percentage of chromosomal DNA damage reduction of three marine 
- algae water extract in repeated in vivo anticlastogenic test. 
Percentage of chromosomal DNA damap reduction 
H. dilatata S, angustifolium S. siliquastrum 
22mg/kg 36 % lOOOmg/kg 28 % lOOOmg/kg 32 % 
2.2mg/kg 31% lOOmg/kg 17% lOOmg/kg 27% 
0.22mg/kg No effect lOmg/kg No effect lOmg/kg 31 % 
0.022mg/kg No effect 1 mg/kg No effect 1 mg/kg 37 % 
83 
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Table 3.21 Estimated ED50 and correlation coefficients of three marine seaweed 
extract in repeated in vivo anticlastogenic test. 
Marine seaweed Estimated ED50, Correlation coefficient, 
extract (mg/kg) r 
H. dilatata 8945 1 
I 上 
S. angustifolium > 25000 1 
S. siliquastrum -0.5866 
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Figure 3.18 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old treated with different concentration of S. angustifolium water extract 
followed with 30 mg/kg EMS. Each represents the median +/- S.E.M. 
of 3 treated mice. Values statistically significantly different from that of 
EMS control group are indicated by * (p<0.05). 
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3.21), the situation was similar to that of H. dilatata. The estimated ED50 (>25000 mg/kg) 
was greatly difference to that (11.17 mg/kg) estimated in screening test (Table 3.21). 
The dosage ofS. siliquastrum used in the triplicate test was different from that 
in in vivo screening test but the results was quite similar (Figure 3.19). The tail moment 
in all dosages were significantly lower than 16.78 土 0.59 for EMS control (P < 0.05). 
Moreover, the chromosomal damage reduction ranged from the lowest 32 % at 100 
mg/kg to the highest 37 % at 1 mg/kg, comparable to 36% at 200 mg/kg and 43% at 2 
mg/kg in the screening test. And the estimated ED50 (0.02 mg/kg) was not great 
difference to that estimation (0.38 mg/kg) in screening test. 
3.4.2 Different treatment methods in in vivo anticlastogenic test 
Only S. angustifolium extract was used in the study of different administration 
methods. 
3.4.2.1 Simultaneous application method (Figure 3.20，Table 3.22, Table 
3.23 and Table 3.24) 
Intraperitoneal (i.p.) treatment results of S. angustifolium showed quite 
different from its oral gavage (p.o.) treatment experiment {S. angustifolium in vivo 
screening test). Firstly, the tail moment decreased from the high dose of, from 20.21 士 
0.37 at 1 g/kg to the low dose of 18.27 士 1.39 at 0.01 g/kg, instead of increasing trend in 
P.O. treatment. This also resulted in the increase in reduction of chromosomal damage 
from 5 0/0 for 1 g/kg to the highest 14 % for 0.01 g/kg. Secondly, i.p. treatment had 
general low percentage in chromosomal damage reduction, below 15 % as compared to 
more than 25 % in the oral treatment. 
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Figure 3.19 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old treated with different concentration of S. siliquastrum water extract 
followed with 30 mg/kg EMS. Each represents the median +/- S.E.M. 
of 3 treated mice. Values statistically significantly different from that of 
EMS control group are indicated by * (p<0.05). 
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Figure 3.20 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old treated with different concentration of S. angustifolium water extract 
through i.p. administration route followed with 30 mg/kg EMS. Each 
represents the median +/- S.E.M. of 3 treated mice. Values statistically 
significantly different from that of EMS control group are indicated by * 
(p<0.05). 
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Table 3.22 The tail moment results of S. angustifolium extract in in vivo 
anticlastogenic test with different treatments. 
Tail moment, mean 士 standard error 
Intraperitoneal ^ Post Pre & Post 
lOOOmg/kg 20.21 ± 0.37 500mg/kg 12.62 士 0.10 __ „ 
lOOmg/kg 19.13 ± 1.74 50mg/kg 10.41 土 U 3 13.72 土 2.08 17.58 ±0.59 
lOmg/kg 18.27 土 1.39 5nig/kg 9.12 土 0.29 15.15 土 2.12 15.06 ±0.38 
Img/kg 18.48 士 1.66 0.5mg/kg 9.49±1.12 14.21士0.81 13.65 土 1.24 
EMS 21.35 土 0.35 EMS 12.71 土 1.22 15.69 ±0.95 1494 士 063 
Control Control 
Solvent 7.99 土 U 6 Solvent 3.11 士 0.15 4.73 士 0.28 6 03 ± 0 39 
Control IControl 
Table 3.23 Percentage of chromosomal DNA damage reduction of S. angustifolium 
water extract in in vivo anticlastogenic test with different treatments. 
Percentage of chromosomal DNA damage reduction 
Intraperitoneal Pre Post 
lOOOmg/kg 5% 500mg/kg 1 Q/。 __ 
lOOmg/kg 10% 50mg/kg 18% 13 o/o 
lOmg/kg 14% 5mg/kg 28% 30/0 
Img/kg 13% 0.5mg/kg 25% 9% 
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Table 3.24 Estimated ED50 and correlation coefficients of S. angustifolium extract in 
in vivo anticlastogenic test with different treatments. 
Different Treatments Estimated ED50, Correlation coefficient, 
(mg/kg) r 
Intraperitoneal (i.p.) 5.8 x 10'^  -0.8860 
Pre-treatment 0.5 -0.8395 
Post-treatment | 53.4 0.2758 
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3.4.2.2 Pre-drug treatment method (Figure 3.21, Table 3.22, Table 3.23 and 
Table 3.24) 
The result pattern was quite similar to that of i.p. treatment but higher 
anticlastogenic effect was found at the lower dosage. Again, the tail moment decreased 
from 12.62 土 0.10 at 500 mg/kg to 9.12 土 0.29 at 5 mg/kg and chromosomal damage 
reduction increased from 1 % at 500 mg/kg to the highest 28 % at 5 mg/kg. 
3.4.2.3 Post drug treatment method (Figure 3.22, Table 3.22, Table 3.23 
and Table 3.24) • 
There were only three dosage results because treated BALB/c mice died at the 
dosage of 500 mg/kg. There was a drop in the tail moment at 50 mg/kg (13.72 土 2.08). 
The percentage of chromosomal damage reduction was low with only a maximum of 13 
% at 50 mg/kg. 
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Figure 3.21 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old which were pre-treated with S. angustifolium water extract for 7 days 
before administration of 30 mg/kg EMS. Each represents the median 
+/- S.E.M. of 3 treated mice. Values statistically significantly different 
from that of EMS control group are indicated by * (p<0.05). 
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Figure 3.22 Comet results of pWBCs of male BALB/c mice in 7-8 weeks 
old which were firstly administrated with 30 mg/kg EMS in 2 hours before 
post-treating of different concentration of S. angustifolium water extract. 
Each value represents the median +/- S.E.M. of 3 treated mice. 
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4 
Discussion 
The aim of this project was to screen for anticlastogenic effect of nine Chinese 
medicinal herbs and three Hong Kong marine algae water extracts against direct acting 
clastogen EMS to peripheral white blood cells (pWBCs) of BALB/c mice, and study 
their possible mechanisms. 
4.1 Cell viability and water extracts of Chinese medicinal herbs and 
marine algae 
Cell viability must be checked in this study because i f cell death, it will result 
in DNA degradation and form DNA fragment. Under comet assay, these apoptotic cells 
would also form comet images that were similar to those caused by clastogenic damage. 
Hence, images from genotoxic damage cells will mixed-up with images from cytotoxic 
dead cells. It was found that cell viability should be greater than 75 % to avoid false 
positive responses due to cytotoxicity (Henderson et al., 1998). As the cell viability in 
all tests in the present study was greater than 90 %, which was much higher than the 
minimum percentage requirement, there should be no false positive results caused by 
cytotoxicity. 
4.2 Clastogenic effect of EMS to pWBCs of BALB/c mice 
In measuring damage cell images or comet images, there are different 
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parameters to quantify the extent of damage. They are tail length, tail intensity, tail 
moment and tail inertia (Hellman et al., 1995; Kinetic Imaging Ltd., 1996). Tail length, 
the displacement of genetic material between nucleus head and tail, is a common 
parameter, which could be measured manually, and was frequency used as an index in 
many single cell gel electrophoresis experiment (Singh et al, 1988, 1989， 1990; 
Kasamatsu et al, 1996; Sasaki et al., 1997a, 1997b). Tail intensity, which reflects the 
amount of genetic material in tail region is not as common as tail length but it was used 
by some authors to present their data (Muller et al., 1996; Scassellati-Sforzolini et al, 
1997). Tail moment, the product of tail length and tail intensity, gives more information 
about DNA damage than tail length or intensity alone does (Singh et al., 1988，1989， 
1990; Olive et al,, 1990). With the introduction of computerized image analysis recently, 
the frequency of using tail moment as an index was increased (Andreoli et a!., 1999; 
Musatov et al., 1999; Venturi et al., 1997; Villarini et al, 1998). Tail inertia is a 
parameter with close correlation with tail moment and may give a better measurement 
of DNA fragment distribution within the tail region (Hellman et al., 1995). The 
advantage of choosing tail moment as DNA damage index in this experiment is that 
may represent both tail length and tail intensity in a single number and does not require 
sophisticated calculation as tail inertia. Although tail inertia may provide information of 
DNA fragment distribution within tails, this information seems not very useful in this 
experiment and its calculation is also sophisticated. Therefore, tail moment was more 
suitable than tail inertia as a DNA damage index in this study. 
As in a population of cells，each cell would receive different intensity of DNA 
damage caused by clastogens, they would give a population of different tail moment 
results. Bauer et al (1998) found that tail moment results were in a chi-square 
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distribution whereas tail intensity and tail length results tend to be normally distributed. 
And Plewa et al. (1999) also found that the tail moment results in antimutagenic study 
of soybean fractions were not in normal distribution. Therefore, mean and standard 
deviation could be used to describe and analyse data of tail intensity or tail length. 
Median and semi-quartile distance (QD) should be used in tail moment result analysis 
(Gad, 1999). 
EMS (Ethyl Methanesulfonate, Sigma Chemical) existed in liquid form with 
density of 1.17 g/ml. However, it is sparely soluble (with solubility 50-100 mg/ml at 
27°C) and white precipitates would always form while mixing with distilled water. It is 
known that LD50 of EMS is 20 |imole-hr/ml for cultured human diploid cells (Kuroda, 
1990a) and is 435 mg/kg and 470 mg/kg for mouse with i.p. and o.p. administration 
respectively. In order to prepare subacute EMS concentration for application, EMS must 
be diluted. Therefore DMSO was served as a solvent and vehicle to dilute EMS with 
distilled water to prevent precipitates formation. DMSO was chose because it is a good 
solvent and vehicle without any harmful effect to mice up to a dosage of 2 ml/kg in i.p. 
administration and 50 % concentration in orally administration (You et al., 1994; Sasaki 
et al., 1997). For in vitro testing, the ideal DMSO concentration should be 1 % 
(Clements, 1995). 
In in vitro testing, 90 ppm of EMS could effectively damage chromosomal 
DNA of pWBCs after 30 minutes of incubation to give measurable images after 
electrophoresis (Figure 4.1). After electrophoresis and staining, comet-like cell images 
could be observed and a distinguished nucleus head and tail of broken DNA migration 
could also be found in each image. This is the result of the migration of broken 
chromosomal DNA out of nucleus (Hellman et al., 1995). A correct and accurate tail 
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Figure 4.1. The formation of carbonium ion from EMS in polar solvents and alkylation 
of guanine with resulting of depurination (Freese, 1971). 
• 
Figure 4.2 Two serious DNA damage pWBCs images by EMS. The images were 
stained with ethidium bromide (5 ng/ml) and in 400x magnification. 
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moment could only be measured in a condition of distinguished head and tail region. 
Otherwise, the computer may incorrectly locate the head and tail region and this in turn 
gave incorrect tail moment result. This incorrect analysis would easily occur when 
chromosomal DNA of a cell was damage so serious that no clear head and tail region 
was found after electrophoresis (Figure 4.2). This was always happened at high EMS 
concentration，for example, 900 ppm and 9000 ppm. Therefore, no data could be 
collected. 
In in vivo testing, a multi-sampling at multi-dose levels pilot experiment for 
EMS was carried out. This method not only could be used to find out the effective 
clastogenic dose of EMS but also the optimum sampling time which is important to 
avoid false negative results (Hayashi et al., 1984). The result showed that, 28 mg/kg of 
EMS was the minimum dosage that could cause clastogenic effect to pWBCs increased 
with time up to 43 hours and resulted in distinguished comet-like images. This effect 
was dropped after 7 days of administration. When the dose was double, the clastogenic 
effect to pWBCs was too serious that most pWBCs chromosomal DNA were totally 
damage even only after 4 hours of administration. As the totally damage chromosomal 
DNA pWBCs would form images without distinguished head and tail region after 
electrophoresis (Figure 4.2), tail moment of these images could not be measured. This 
effect was decreased with time but there were still many immeasurable cell images at 43 
hours after administration. Therefore, tail moment result of the dose at 56 mg/kg for 43 
hours was low because non-measurable damage cell images were incorrectly analyzed 
by Komet to give low tail moment results. As the clastogenic effect further decreased, 
more cell images could be measured and so tail moment result was increased as shown 
in Figure 2.2. For higher EMS dosage, the clastogenic effect was much stronger and it 
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took longer time for the effect to decrease to a measurable level. This could be shown 
by more serious damage and non-measurable cell images in 225 mg/kg treatment group 
than in 112 mg/kg that of group. As a result, 225 mg/kg gave lower tail moment results 
than that of 112 mg/kg at day. 
As a whole, 90 ppm and 28 mg/kg of EMS was used as the optimum 
concentration and dosage to induce clastogenic effect in in vitro and in vivo test. 
4.3 In vitro anticlastogenic screen test of nine water extracts of 
Chinese medicinal herbs and three water extracts of marine algae 
Tail moment result could give information of DNA damage of cell by EMS but 
it could not directly reveal anticlastogenic effect of substrates against clastogen EMS. 
Therefore，percentage of chromosomal DNA damage reduction would be used. This 
was calculated from dividing the difference of tail moment result between EMS control 
and testing substrate by tail moment result of EMS control. 
From the screening results of Chinese medicinal herb extracts, their maximum 
anticlastogenic effect were in this order, EZ > QCG > BYZ > SL > JJC > SDG > MDL 
> F J > XHC (no effect). Where BYZ, EZ and QCG had a relative clear anticlastogenic 
effect against EMS but most of them had around 30 % reduction effect. Although their 
dose-response relationships were not very clear, the trend could still be found. For BYZ 
and QCG, their anticlastogenic response increased with increased concentration. It was 
easy to understand because of the increase of the active components. In contrast, EZ 
showed that anticlastogenic effect was decreased when concentration was increased. It 
might be due to the presence of some chemicals in the water extract that interrupted the 
anticlastogenic effect of the active components. When the concentration of EZ 
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decreased, both active components and interrupting chemicals amount were also 
decreased. However, the effect of interrupting chemicals might decrease sharply with 
decreased concentration than that of anticlastogenic effect of the active components. 
Then, the interrupting effect to anticlastogenic effect of active components would be 
much lower than that in higher concentration and as a result, anticlastogenic effect 
would be increased with concentration decreased. These interrupting chemicals could be 
mutagens, comutagens and promutagen activators (Sarkar and Sarma, 1996). In 
moderate and weak anticlastogenic effective groups (MDL, SDG, SL, FJ and JJC), they 
also demonstrated increased anticlastogenic response with decreased concentration. 
Although XHC did not give any anticlastogenic effect in the screening concentrations, 
the result clearly showed that tail moment results decreased with lower concentration 
and it was same for clastogenic effect. The result might simply due to decreasing of 
mutagenic substances while XHC concentration decreased. In XHC extract, there might 
be some anticlastogenic substrates present in but their effect were covered by 
interrupting substances. If these anticlastogenic and interrupting substances were also 
behaved as describe before, XHC may have clastogenic effect against EMS in lower 
concentration. 
In comparing with extraction percentage of nine Chinese medicinal herbs, i.e. 
BYZ > XHC > QCG > EZ > JJC > SDG = SL > MDL > FJ, it was not difficult to find 
that the three strongest anticlastogenic effect herb extracts (BYZ, EZ and QGC) were in 
the first four highest extraction percentage. Thus, the strength of anticlastogenic effect 
may relate to the efficiency of extraction of herbs. I f the maximum percentage of 
chromosomal DNA damage reduction of each extract was corrected by dividing it with 
its extraction percentage, a so-called 'anticlastogenic power' of each Chinese medicinal 
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herb was obtained (Table 4.1). In most extracts, they displayed negative dose-response 
relationship in anticlastogenic effect. This might be due to the presence of many active 
and destructive components in the crude extracts. Therefore, it would not have stronger 
antigenotoxic effect in higher concentration as some purified or isolated antigenotoxic 
substances did (Anderson et al, 1997; Han, 1997; Keshava et al, 1997/98; Musatov et 
al, 1999; Plewa et al., 1999; Anisimov et al., 2000). Concentration factor might be 
misleading and was neglected in the crude extract 'anticlastogenic power' calculation. 
From this table, the anticlastogenic power of each herb could be arranged as follow: EZ 
> QCG « SL〉SDG « F J « MDL « JJC « BYZ. The result showed that most herbs had 
similar anticlastogenic power. 
For marine algae, the three seaweed water extracts generally expressed stronger 
anticlastogenic effect than that of Chinese medicinal herb extracts. Each of them had 
nearly maximum 40 % reduction in chromosomal DNA damage. As most herb extracts, 
they clearly displayed negative dose-response relationship of anticlastogenic effect. The 
order of anticlastogenic effect of them was S. angustifolium > H. dilatata > S. 
siliquastrum. However, their extraction percentage order was S. angustifolium > S. 
siliquastrum > H. dilatata. When extraction percentage was considered, their 
anticlastogenic power could be calculated (Table 4.2) and the order was S. siliquastrum 
> H. dilatata > S. angustifolium. The higher anticlastogenic power of three seaweed 
extracts was mainly due to their low extraction percentage. As H. dilatata and both 
Sargassum spp. were aquatic plants, they contained a lot of water in the plant body 
(Chan et al, 1997). About 80 % to 90 % of their wet weight were water. If the water 
content was excluded in extraction percentage calculation i.e. dry weight of seaweeds, 
the percentage of extraction was increased about eight times and anticlastogenic power 
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Table 4.1 Anticlastogenic power of Chinese medicinal herbs 
Chinese Maximum Extraction Anticlastogenic 
medicinal herbs reduction, MR percentage, EX power 
= M R / E X 
BYZ 28.17 38 0.74 
EZ 36.70 17 2.16 
FJ 5.39 6 0.90 
JJC 12.39 15 0.83 
MDL 9.62 11 0.87 
QCG 31.18 19 1.64 
SDG 11.77 13 0.91 
SL 16.04 13 1.23 
XHC No effect 24 -
Table 4.2 Anticlastogenic power of marine algae 
Marine Maximum Extraction Anticlastogenic 
algae reduction, MR percentage, EX power 
m (%) = M R / E X 
H. dilatata 39.02 1.04 (13.00') 35.96 (3.00、 
S. angustifolium 44.44 2.94(14.7") 15.12(1.03^) 
S. siliquastrum 37.63 1.21 (6.37') 3 1 . 1 0 ( 4 . 8 8 � 
a Extraction percentage was corrected by dividing (1- fresh seaweed moisture content), 
b Anticlastogenic power was calculated from corrected extraction percentage. 
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of them was decreased to 1.03 for S. angustifolium, 4.88 for S. siliquastrum and 3.00 for 
H. dilatata. Thus their anticlastogenic power order could be rearranged as follows: S. 
siliquastrum > H. dilatata > S. angustifolium. It was noteworthy that S. angustifolium 
had similar anticlastogenic power as most herb extracts but anticlastogenic power of H. 
dilatata and S, siliquastrum was either same or two times greater than that of E Zu. 
Recently, through personal communication, it was reported that both 
seaweed, S. siliquastrum and S. angustifolium, extracts had antioxidant activity. It is 
known that alkylation of DNA by alkylating agent may induce point mutations, 
chromosome breaks and chromosome mutations. In polar solvent, alkylating agents give 
rise to positive carbonium ions, which will react readily with nucleophilic groups in 
DNA (e.g. 7N position of guanine). I f guanine is alkylated, it wil l hydrolyze from DNA 
and the backbone of the unstable depurinated DNA breaks (Freese, 1971). This 
oxidation damage could be prevented by antioxidant through scavenging reactive 
carbonium ions or their precursors, inhibiting carbonium ions formation or upregulation 
of endogenous antioxidant defenses (Halliwell, 1997). Therefore, higher antioxidant 
effect of extract may result in higher antigenotoxic activity.. The antimutagenic activity 
of flavonoids is most probably a consequence of their antioxidant properties (Korkina 
and Afanas'ev, 1997). According to the theory, S. angustifolium might have higher 
antioxidant effect than that of S. siliquastrum because S. angustifolium extract had 
stronger anticlastogenic effect. However it found that 0.25 mg/ml oiS. siliquastrum and 
S. angustifolium extracts showed 98 % and 18 % of peroxidation inhibition respectively. 
The results were opposite to the prediction. 
4.4 In vitro anticlastogenic mechanisms investigation of three 
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marine algae extracts 
In the lacking of knowledge of the mechanisms of inhibiting carcinogenesis 
processes, Watterberg (1990) had proposed to classify inhibitors according to the time 
in carcinogenesis process at which they are effective. Similarly, Kuroda (1990b) 
summarized antimutagenesis into two processes, desmutagenesis and 
bio-antimutagenesis. Desmutagenesis is described as a process of modulators 
(desmutagens) which directly act on mutagens or their precursors and inactivate them. 
Modulators which act on the processes of mutagenesis or repair DNA damage to result 
in decreasing mutation frequency are bio-antimutagens, and the process of actions is 
called bio-antimutagenesis. Two processes are summarized in Figure 4.3 (Kuroda, 
1990b; Gebhart and Arutyunyan, 1991). The mechanisms of desmutagenesis involve 4 
processes: (i) chemical inactivation of mutagens, (ii) enzymatic inactivation of 
mutagens, (iii) inhibition of metabolic activation of promutagens, (iv) inactivation of 
activated mutagens, including scavenging (Kuroda, 1990b). While, bio-antimutagens 
could act on various repair and replication processes to normalize or reduce the DNA 
damage. These processes could include SOS repair system, excision repair system, 
recombination repair system, excision and transfer of alkylated bases process, and DNA 
replication process. Figure 4.4 is an example of DNA repair processes in E. coli in 
which DNA damage was induced by physical and chemical agents (Kuroda, 1990b). As 
antimutagenesis processes could occur outside or within the cell, de Flora and Ramel 
(1988) classified inhibitors which inactivate extracellular mutagens, prevent the 
formation or uptake of mutagens as extracellular antimutagens, and inhibitors which 
function within the cells were classified as intracellular antimutagens. When we make a 
comparison between classification of Kuroda and that of de Flora and Ramel, we find 
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Figure 4.3. Schematic shows possible pathway of a normal cell change to mutant 
cell and subsequently to cancer cell. It also shows possible antimutagenesis processes 
by desmutagen and bioantimutagen (Kuroda, 1990b; Gebhart and Arutyunyan, 1991) 
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that desmutagens can be extracelluar or intracellular antimutagens but bio-antimutagens 
would be intracellular antimutagens only. 
de Flora et al. (1992) had designed three methodological variations, i.e. 
pre-treatment, co-treatment and post-treatment of bacteria with modulatory activity to 
illustrate the possible inhibition mechanisms. The possible modulation mechanisms 
revealed by three treatments were as follows: (i) pre-treatment demonstrating 
intracellular reaction of the modulator with the test mutagen, or interference with 
cellular mechanisms leading to its genotoxicity, (ii) co-treatment demonstrating 
extracellular reaction of the modulator with the test mutagen or with components of the 
exogenous metabolic system, (iii) post-treatment demonstrating effect of the modulator 
on DNA repair, fixation and expression of DNA damage produced by the test mutagen. 
From the possible mechanisms revealed by pre-, co- and post-treatments, they could 
also be used as a measure to evaluate modulators belonging to desmutagens or 
bio-antimutagens. If modulator gave positive result only in co-treatment test, it should 
be bio-antimutagens. I f modulator gave positive result in pre- or co-treatment test, it 
should be desmutagens. However, there is possible for a modulator with both 
desmutagen and bio-antimutagen properties, and then, it wil l show positive results in all 
three treatment tests. 
With the modified pre-, co- and post-treatment methods, the possible 
anticlastogenic mechanisms of three marine algae extracts were studied in the present 
study. In these three treatment experiments, all seaweed extracts showed anticlastogenic 
effect against EMS and each extract had different percentage in structure DNA damage 
reduction in three treatments. This probably indicates that anticlastogenic effect of all 
seaweed extracts involved three mechanisms and different anticlastogenic mechanisms 
106 
Discussion 
shared different strength in anticlastogenic effect. It could be due to three extracts 
containing desmutagens and bio-antimutagens or modulators with both activities. Their 
fraction in the extract would be different and they would also have different ability in 
anticlastogenic activity. Therefore, each extract would result in different anticlastogenic 
effect in the three treatments. H. dilatata results showed that the average anticlastogenic 
effect in the post-treatment was 2 times and 3 times respectively greater than that in 
pre-treatment and co-treatment. Clearly, H. dilatata extract could have more 
bio-antimutagens than desmutagens or desmutagens did not effectively inactivate the 
action of EMS as the activities of bio-antimutagens. Thus, anticlastogenic effect of H. 
dilatata was mainly through bio-antigenotoxic processes. For S. angustifolium, the 
extract gave similar high anticlastogenic effect in the three treatments so three 
mechanisms might share similar anticlastogenic strength in the extract. Both modulators, 
desmutagens and bio-antimutagens, could have overall similar anticlastogenic activity 
even in the same or different concentration. For S. siliquastrum, the average 
anticlastogenic effect in the post-treatment was about 1.4 times or 2 times greater than 
that in pre or co-treatment. This indicated that the effect of extracellular reaction of the 
modulator with the test mutagen or with components of the exogenous metabolic 
system was less than the two other mechanisms in anticlastogenic activity. However, 
the similar anticlastogenic effect between pre- and post-treatment showed that 
intracellular desmutagenic activities would have comparative strength with 
bio-antimutagenic activities. I f summation of the average chromosomal DNA damage 
reduction percentage of three treatments was treated as overall anticlastogenic effect, S. 
angustifolium had the highest percentage and H. dilatata had similar percentage with S. 
siliquastrum. These results were quite agreed with their in vitro screening results. 
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As all seaweed extracts were crude extracts and their component contents were 
very complicated, there could have many possible reactions happened in the tests. 
Therefore, having positive anticlastogenic results in all treatment tests of three extracts 
would not be surprised. In order to have a clear evaluation, isolation and purification of 
active components from the extracts and identification of their activities required further 
investigation. However, the existing mechanism evaluation results gave some 
explanation to the in vivo screening results of three seaweed extracts which were dealt 
with in the coming section, 
4.5 In vivo anticlastogenic screen test of Chinese herb extracts and 
seaweed extracts 
In the in vivo anticlastogenic screen test of Chinese herbs extracts, San Ling 
(SL), Jiu Jie-cha (JJC) and Ba Yue-zha (BYZ) were selected because they had different 
anticlastogenic strength groups in the in vitro screen test. BYZ represented the strongest 
anticlastogenic group, SL and JJC were represented the second and third anticlastogenic 
strength group in in vitro test. Theoretically, the validity of in vitro test could be verified 
by in vivo experiment. In other word, in vitro test result could predict in vivo test result, 
if in vitro test is valid. Thus, i f the anticlastogenic effect order of the three Chinese herb 
extracts from three different anticlastogenic strength groups in the in vitro test could 
match with their strength order of anticlastogenic effect in the in vivo test, this in vitro 
test assay should be a valid assay for a prediction of in vivo result. From the results, it 
was found that the anticlastogenic effect of these three Chinese herb extracts was 
different between in vitro and in vivo test. In the in vitro test, anticlastogenic effect was 
BYZ > SL > JJC but iri in vivo test, the result was JJC > SL > BYZ. As mentioned 
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previously, however, when extraction percentage was considered, both in vitro and in 
vivo anticalstogenic power were SL > JJC > BYZ (Table 4.1 and 4.3). Therefore, in 
vitro screen test was still valid in the prediction of in vivo results. However, the 
insignificant anticlastogenic effect of SL in repeating in vivo test indicated that more 
tests should be done for verification. 
In in vivo anticlastogenic results, the different effective time of different 
Chinese herb extracts could be due to their different anticlastogenic mechanisms. For 
those，which did not required enzymatic activation and inhibited mutagen directly 
would give their effect earlier. On the other hand, some could require activation before 
starting anticlastogenic function. Although there had no any in vitro or in vivo 
anticlastogenic mechanisms study of these three Chinese herbs extracts, JJC had effect 
earlier than those of SL and BYZ revealed that JJC might require none or less 
enzymatic activation or its activation processes was much faster than that required by 
SL and BYZ. This could be true for the earlier effect of SL than that of BYZ. Of course, 
“ there were many other factors that could affect the modulator effect, e.g. absorption, 
distribution, biotransformation and elimination. This pharmacokinetic information is 
very useful in the prediction or monitoring the metabolic products, the duration of the 
effect, the sequestration into body compartments, and the route of elimination (Barile, 
1994). Therefore, their pharmacokinetics should be studied further. 
For marine algae extracts, their anticlastogenic effect showed different 
spectrum. For S. siliquastrum and H. dilatata, the anticlastogenic effect was increased 
with time and reached maximum percentage at 12 and 24 hours after administration 
respectively. In contrast, S. angustifolium had maximum effect at 6 hours and its 
anticlastogenic effect was decreased with time. The order of their in vivo anticlastogenic 
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Table 4.3 In vivo anticlastogenic power of Chinese medicinal herbs 
Chinese Maximum Extraction Anticlastogenic 
medicinal herbs reduction, MR percentage, EX power 
= M R / E X 
BYZ 12.32 38 0.32 
JJC 52.23 15 3.48 
SL 50.27 13 3.87 
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effective time was S. angustifolium (6 hours) < S. siliquastrum (12 hours) < H. dilatata 
(24 hours). S. angustifolium could have such earlier anticlastogenic effect was probably 
because its modulators could effectively inactivate EMS extracellularly. This could be 
proved by S. angustifolium having relatively strong anticlastogenic effect in the 
co-treatment test as compared with the pre- and post-treatment test. Besides, the early 
occurrence of anticlastogenic effect of S. angustifolium probably showed that these 
modulators might not require bio-transformation or through several enzymatic pathways 
to inactivate the direct-acting mutagen, EMS. However, there was still not enough 
evident to draw such a conclusion because the action of digestive enzymes or the 
metabolic activity of bacteria in the intestine could modify compounds in the extract 
(Walum et al, 1990). After 6 hours, the anticlastogenic effect of S. angustifolium was 
greatly decreased. The fast drop of anticlastogenic action pointed out that the active 
modulators would no longer exist in the mouse body. This could be due to: 1) the 
modulators elimination was very fast; 2) metabolization of these modulators to inactive 
‘metabolites was highly effective. 
For S. siliquastrum, it required longer time for effective anticlastogenic 
activities probably because the modulators might not react directly and extracellularly 
with EMS but required bio-transformation before blocking action of EMS and they 
might have to take time to activate repaired system to fix the DNA damage. This could 
be shown by a better anticlastogenic performance of S. siliquastrum extract in the 
post-treatment than that in the pre-treatment which anticlastogenic result was even 
better than that of co-treatment mechanism test. Therefore, i f siliquastrum modulators 
could retain in mice for longer time before EMS administration, the number of cells 
getting with modulator and the amount of modulators getting inside the cell would be 
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increased. Then, stronger anticlastogenic effect would it be. However, the elimination of 
modulators and their metabolisms would reduce the amount of modulators existing in 
mice so anticlastogenic effect was dropped at 24 hours after administration. This could 
show that the elimination and metabolism rate of S. siliquastrum modulators was slower 
than that of S. angustifolium. 
The anticlastogenic effect of H. dilatata was increased with time and reached 
maximum at 24 hours after administration. This could show that more and more H. 
dilatata pro-modulators were transformed to active modulators with time. However, it 
was also believed that more DNA repaired systems would also be activated by 
modulators i f longer time was allowed. This was because H. dilatata had positive 
anticlastogenic effect in the pre-treatment test and a dominant anticlastogenic effect in 
post-treatment test. Although extracellular reactions with EMS, which was shown by 
lower anticlastogenic effect in the co-treatment test, would be happened, intracellular 
reactions should be more important because most bio-transformation reaction and all 
DNA repaired processes were inside the cell. Therefore, the longer H. dilatata extract 
remained in mice, the stronger anticlastogenic effect it would be. Of course, the 
elimination and metabolism rate of the modulators should be ineffective and slow 
enough; otherwise active modulators could not accumulate with time. It seems true for 
the in vivo screening result of H. dilatata. 
From the results, it was found that the order of maximum anticlastogenic 
reduction percentage of three marine algae extracts was same in both in vitro and in vivo 
test (S. angustifolium > H. dilatata > S. siliquastrum). Although they had different order 
in the anticlastogenic effect, three algae showed same anticlastogenic power order in 
both tests (//. dilatata > S. siliquastrum > S. angustifolium). When the anticlastogenic 
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power was corrected with consideration of seaweed moisture content (Table 4.4), they 
were found different in both tests. In the in vivo test, the order was S. siliquastrum > S. 
angustifolium > H. dilatata, whereas in the in vitro test, the order was S. siliquastrum > 
H. dilatata > S. angustifolium. In both in vitro and in vivo tests, the corrected power of 5. 
siliquastrum was about 1.6 times greater than that of H. dilatata. However, the 
difference of corrected anticlastogenic power of S. siliquastrum to that of S. 
angustifolium in the in vivo test was much lower than that in in vitro test. In the in vivo 
test the corrected power of S. siliquastrum was just 1.4 times greater than that of S. 
siliquastrum but it got 4.7 times higher in the in vitro test. Although they had different 
corrected power order between in vitro and in vivo tests, it was acceptable that the in 
vitro test was still reliable because both tests could show S. siliquastrum having the 
strongest corrected anticlastogenic power. 
When the anticlastogenic tests of three seaweeds were repeated in triplicate, all 
of them could give positive anticlastogenic effect but the extent was less than that in the 
screen test. For S. siliquastrum, its maximum anticlastogenic effect was 37 %, which 
was close to that in the screening test (49 %). For H. dilatata, the aniclastogenic effect 
was only found in the two highest testing dosages with a maximum percentage of DNA 
damage reduction only 36 %, which was about a half of its result in the in vivo 
screening test. Similarly) S. angustifolium also had positive effect at the two highest 
dosages. However, the reduction percentage was only 28 %, which was about three 
times less than the value in the in vivo screening test. These differences might be due to 
insufficient number of in vitro and in vivo tests. Therefore, more tests are suggested to 
improve the reliability. 
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Table 4.4 In vivo anticlastogenic power of marine algae extracts 
Marine Maximum Extraction Anticlastogenic 
algae reduction, MR percentage, EX power 
= M R / E X 
H. dilatata 63.50 1.04 (13.00') 61.06 (4.89") 
S. angustifolium 82.10 2.94 (14.7” 27.93 (5.59、 
S. siliquastrum 48.80 1.21 (6.37') 40.33 (7.66、 
a Extraction percentage was corrected by dividing (1- fresh seaweed moisture content), 
b Anticlastogenic power was calculated from corrected extraction percentage. 
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4.6 Different administration methods in in vivo anticlastogenic test 
4.6.1 Intraperitoneal route of administration 
The different anticlastogenic results between i.p. route and o.p. route of 
administration showed that o.p. route administration was more effective than i.p. route 
administration with high dosage but vice versa in low dosage. The high anticlastogenic 
effect of extract in o.p. route with high dosage might be due to some extract components 
(including active and inactive) being metabolized by microflora in the mouse gut into 
more active forms. However, these metabolized components might be difficult to be 
absorbed into body and therefore the actual amount of active components being 
absorbed would be less than expected. Thus, administration dosage should be high 
enough so that there would be enough amount of active components to give 
anticlastogenic function. This in turn resulted in anticlastogenic effect be found in high 
dosage but not in low dosage in o.p administration. In contrast, in i.p. route 
administration, there was no acid-labile chemical decomposition in the stomach, no 
absorption of test substrates with food component and no microflora metabolization of 
test substrate in the gut, substrates could directly enter into the body (Shelby, 1986). 
Therefore, there would be impossible to have any loss and change of extract through 
gastrointestinal tract, and the extract administered, in term of quality and quantity, 
should be totally entered into mice body. Although there was no metabolized activation 
processes by microflora, the already active components in the extract were in enough 
amount to exert anticlastogenic effect in low applying dosage in i.p. administration. 
However, the anticlastogenic effect decreased with dosage applied (Table 3.23 and 
3.24 )• This inversed relationship between dosage and percentage of chromosomal DNA 
damage reduction showed that there might be also presence of some products which 
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would inactivate anticlastogenic substances or activate clastogenic substances. Sarkar 
and Sarma (1996) claimed that natural plant extracts would present mutation products 
and some plant products which may inactivate the action of some known mutagens on 
living organisms by desmutagenic activity or biomutagenic activity but there would also 
some plant products which may give synergistic effect with the existing mutagens or 
activate promutagens into mutagens within the cell. Therefore, i f dosage was 
increased, there would be more mutagens, comutagens and promutagens activators to 
increase the probability of mutation. The increasing mutation effect would overwhelm 
the antimutagenic effect of the increasing antimutagenic products and as a result 
antimutagenic effect would decrease with dosage. 
With regarding to the factors which would modify or influence test substrates 
in o.p. route administration, i.p. route would be suggested to be used in the primary 
screening (Shelby, 1986). On the other hand, oral route is a common and easy route to 
exposure and administration. The possible reactions of substrates within the 
gastrointestinal tract should be considered and o.p. route administration must be chosen 
(Hayashi et al, 1989). 
4.6.2 In vivo pre- and post-treatment methods 
It was found that the different route administration methods would affect the 
anticlastogenic effect of S. angustifolium extract. Although both, i.p. and o.p., methods 
were different in the route of administration, the treatment schedule of S. angustifolium 
extract and EMS in the two methods was same. As the time between the treatment ofS. 
angustifolium extract and EMS was close, this treatment schedule could be classified as 
simultaneous or co- treatment method. In order to find out the effect of treatment 
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schedule of S. angustifolium extract, the extract was i.p. administered into mice once a 
day for a total of seven days before administration of EMS and this was pre-treatment 
method. Another method, post-treatment method, the extract would be administered 
following EMS. These in vivo treatment methods were not used to investigate the action 
mechanisms of modulators as in vitro mechanism investigation methods did. They 
could only give us information of anticlastogenic effect of the extract in different 
treatment. 
From the results, S. angustifolium extract had better anticlastogenic 
performance in the pre-treatment than in i.p. administration test (simultaneous treatment) 
or in the post-treatment test. Both pre- and simultaneous treatment tests had similar 
negative dose-response curve with DNA damage reduction percentage plateau at two 
higher dosages. However, the anticlastogenic effect of pre-treatment test was two times 
greater than that of simultaneous treatment test even the doses being double. The 
difference of pre-treatment test and simultaneous treatment test was that only the extract 
being administered into mice for seven times in seven days but only once extract 
treatment in the simultaneous test. From the negative dose-response curve, the higher 
dosage would not result higher anticlastogenic results so longer extract treatment should 
get more substrates inside the body, which in turn, should cause a decrease of the 
anticlastogenic effect. As explained before, higher extract dosage with lesser 
anticlastogenic effect was probably due to the present of some mutagenic substrates in 
the extract (Sarkar and Sarma, 1996). However, i f the metabolism of these mutagenic 
substrates was faster than that of modulators, it was possible that more effective 
modulators could accumulate within the body after a period of treatment and the 
anticlastogenic effect would be higher as compared to the corresponding dosage in the 
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simultaneous treatment. Besides, it was possible for more non-active modulators being 
transformed to active modulators in the longer treatment. As S. angustifolium had a 
significant anticlastogenic effect in in vitro pre-treatment test, the modulators of S. 
angustifolium should react intracellularly with the test mutagen, or interfere with 
cellular mechanisms leading to its genotoxicity (de Flora et al., 1992). These 
intracellular reaction could be inhibition of cell replication, keeping mutagens away 
from non target cells, inducing detoxifying mechanisms, blocking reactive molecules 
via reactions with electrophils chemically or enzymatically or via protecting 
nucleophilic sites of DNA (de Flora and Ramel, 1988). Therefore, longer treatment time 
would favour these intracellular reactions even in lower dosage. 
In the absence of treatment of S. angustifolium before EMS administration, the 
anticlastogenic effect was comparatively low in the post-treatment test. Although S. 
angustifolium shared same anticlastogenic effect in the in vitro post-treatment test as 
pre- and co-treatment tests, the in vivo post-treatment results showed there was only 
about one third anticlastogenic effect of in vivo pre-treatment test. This was because the 
anticlastogenic result of pre-treatment by any protective processes, as mentioned before, 
was a result of relatively long period of sample treatment. However, there were only 
two treatments in the post-treatment test. Therefore lower anticlastogenic effect of 
post-treatment might be due to lower amount of modulators. It was also worth 
mentioning that the close administration between EMS and first injection of S. 
angustifolium in the post-treatment test, only 2 hours different, could be treated as a 
simultaneous treatment. Therefore, the post-treatment test also had simultaneous 
treatment element and higher anticlastogenic result would be expected. However, 
simultaneous and post-treatment showed comparable anticlastogenic effect. This might 
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be because modulators using in extracellular reaction with the test mutagen or with 
components of the exogenous metabolic system were same with modulators using in 
DNA repair, fixation and expression of DNA damage produced by the test mutagen. In 
the condition of same anticlastogenic strength of modulator in extracelluar reaction and 
DNA repairing which was confirmed by same anticlastogenic effect of in vitro co- and 
post-treatment, there should be more or less same the anticlastogenic effect between 
simultaneous treatment and post-treatment, no matter the modulators in the 
post-treatment test being used in extracellular reaction or DNA repairing. 
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5 
Summary and Conclusion 
In both in vitro and in vivo tests, the clastogenic effect of ethyl 
methanesulfonate (EMS) on peripheral white blood cells of male BALB/c mice could 
be detected by single cell gel electrophoresis assay (Comet assay). Under in vitro 
condition, only a dose of 90 ppm and an interval of 30 minutes were enough for it to 
damage chromosomal DNA of white blood cells to a satisfied measurable detection. For 
VIVO test, a dose of 28 mg/kg and an interval of 43 hours would be required to give a 
satisfied damage results. However, chromosomal damage would be too strong and 
undetectable i f only doubling the dosage. 
Nine Chinese medicinal herbs and three Hong Kong seaweeds were 
successfully prepared by water extraction and lyophilization to dry powder. The 
extraction percentage of Chinese medicinal herbs were different and were listed from 
higher to lower value as follows: BYZ (38 %), XHC (24 %), QCG (19 %), EZ (17 %), 
JJC (15 %), SDG (13 %), SL (13 %), MDL (11 %) and FJ (6 %). With these water 
extract powders, a set of different concentrations of different herb solution were 
prepared and screened for anticlastogenic activity using in vitro assay. Based on their 
maximum anticalstogenic effect, they could be generally divided into four groups. The 
first group were BYZ, EZ and QCG. They showed the strongest anticlastogenic effect 
among all herbs and had about 30 % reduction effect. The second group were MDL, 
SDG and SL. They only gave moderate anticlastogenic effect with around 10 % 
reduction effect. FJ and JJC were the third group and only had weak anticlastogenic 
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effect with 5 % to 10 % reduction effect. The last group was XHC which did not show 
any protective effect against clastogenic effect of ethyl methanesulfonate. When their 
maximum anticlastogenic effects were compared, there would have such anticlastogenic 
effect order : EZ > QCG > BYZ > SL > JJC > SDG > MDL > FJ > XHC (no effect). 
However, when the variation of extraction efficiency was considered, anticlastogenic 
power of different herbs could be revealed, and the order was as follows: EZ > QCG « 
SL > SDG « FJ « MDL « JJC « BYZ. Different to the anticlastogenic effect, most herbs 
would have similar anticlastogenic power. This difference was simply because 
extraction efficiency factor was taken into account in anticlastogenic power but was not 
considered in anticlastogenic effect. No matter of which calculation method, EZ, QCG 
and SL were still shown stronger anticlastogenic activity among all the herbs. 
In in vivo anticlastogenic screen, BYZ, SL and JJC from three different 
anticlastogenic groups showed highest anticlastogenic effect at different administration 
time intervals. BYZ had highest anticlastogenic effect of 12 % at 24 hours 
administration schedule. SL got 50 % reduction effect at 12 hours administration 
schedule. JJC had highest 52 % at 6 hours administration schedule. The order of 
anticlastogenic effect in in vivo test was opposite to the order in in vitro test. However, 
their anticlastogenic power order were the same in both tests, i.e. SL > JJC > BYZ. This 
implied the reliability of in vitro screen test. 
For marine algae, with more than 80 % of their body weight was water, their 
extraction percentage were low as compared to extraction of other medicinal herbs, and 
their order was H. dilatata (1.04 %), S. siliquastrum (1.21 %)，S. angustifolium (2.94 %). 
Although their extracts generally had anticlastogenic effect around 40 % which was 
higher than the effect of nine Chinese herbs extracts, their anticlastogenic power were 
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not much higher but close to the power of Chinese herbs when extraction efficiency was 
considered. As compared to S. siliquastrum, the higher anticlastogenic effect of S. 
angustifolium should not be the contribution of antioxidative activities because S. 
siliquastrum had higher antioxidative effect than that of S. angustifolium. However, 
under the lower extraction efficient of S. siliquastrum, its anticlastogenic power was 
greater than that of S. angustifolium. For H. dilatata, both anticlastogenic power and 
effect of extracts were in the second place among three marine algae. 
In all crude seaweed extracts, the complex mixtures could have various 
mechanisms to inhibit anticlastogenic effect induced by ethyl methanesulfonate but the 
dominant mechanism was still found in K dilatata and S. siliquastrum. H. dilatata 
extract modulators were active in DNA repair, fixation and expression of DNA damage. 
In S. siliquastrum, with similar anticlastogenic strength in pre- and post-treatment, 
modulators were not only active in DNA repair, fixation and expression of DNA 
damage but also actively reacting with clastogen within cells to interfere cellular 
mechanisms leading to its genotoxicity. The performance of S. angustifolium in pre-, 
CO- and post-treatment proved that its modulators had equal reactivity with clastogens in 
extracellular and intracellular conditions. Moreover, DNA repairing processes aroused 
by S. angustifolium modulators also shared equal importance in anticlastogenic effect 
with extra- and intra-cellular reactions. 
In in vivo anticlastogenic screen test, the anticlastogenic effect order of 
three seaweed extracts was same to the order in the in vitro screen, i.e. S. angustifolium 
〉H. dilatata > S. siliquastrum. Each seaweed extract was found to have the highest 
anticlastogenic effect at a different administration time interval. S. angustifolium 
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showed highest 82 % anticlastogenic effect early at 6 hours administration schedule. S. 
siliquastrum got a maximum of 35 % at 12 hours administration. H. dilatata required 24 
hours to reach maximum 64 % anticlastogenic effect. Generally, their anticlastogenic 
effect was greater than that of the three potent Chinese herbs extracts. The effective 
time pattern of three marine seaweed extracts were matched with the predictions and 
explanations of their in vitro mechanisms studies. However, the maximum percentage 
anticlastogenic effect of S. angustifolium and H. dilatata extracts were decreased at least 
a half when the test was repeated. Therefore, further investigation was required. 
This shows that the route of administration could interfere the 
anticlastogenic results. The result was different in different dosages. At lower dosage, S. 
angustifolium had higher anticlastogenic effect in i.p. route administration as more 
modulators got into mice through i.p. administration route. However, p.o route 
administration was superior than i.p. administration at high dosage. This could be due to 
the extract mixtures contained more mutagens, comutagens or promutagens which 
entered the mice through i.p. route. In the i.p. administration, the prolonged treatment of 
extracts at lower dosage had. better anticlastogenic effect than simultaneous and post 
treatments. The latter two treatments had similar extent of anticlastogenic effect. 
Finally，single cell gel electrophoresis assay is a simple and sensitive method 
to detect DNA breakage at a low cost. Therefore it is a good tool to study 
anticlastogenic and clastogenic substances. It can be used to monitor genotoxic effect in 
animals and even in human. However, the possible uncertainty in electrophoresis should 
be improved to increase the result reproducibility. 
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